<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PeerJ</journal-id><journal-id journal-id-type="iso-abbrev">PeerJ</journal-id><journal-id journal-id-type="publisher-id">peerj</journal-id><journal-title-group><journal-title>PeerJ</journal-title></journal-title-group><issn pub-type="epub">2167-8359</issn><publisher><publisher-name>PeerJ Inc.</publisher-name><publisher-loc>San Diego, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12101441</article-id><article-id pub-id-type="publisher-id">19429</article-id><article-id pub-id-type="doi">10.7717/peerj.19429</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioinformatics</subject></subj-group><subj-group subj-group-type="heading"><subject>Molecular Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group><subj-group subj-group-type="heading"><subject>Infectious Diseases</subject></subj-group><subj-group subj-group-type="heading"><subject>COVID-19</subject></subj-group></article-categories><title-group><article-title>Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis</article-title></title-group><contrib-group><contrib id="author-1" contrib-type="author"><name><surname>Eltayeb</surname><given-names>Ahmed</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib id="author-2" contrib-type="author"><name><surname>Adilovi&#x00107;</surname><given-names>Muhamed</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib id="author-3" contrib-type="author"><name><surname>Golzardi</surname><given-names>Maryam</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib id="author-4" contrib-type="author"><name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>Altijana</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib id="author-5" contrib-type="author"><name><surname>Rubio-Casillas</surname><given-names>Alberto</given-names></name><xref rid="aff-3" ref-type="aff">3</xref></contrib><contrib id="author-6" contrib-type="author" corresp="yes"><name><surname>Uversky</surname><given-names>Vladimir N.</given-names></name><email>vuversky@usf.edu</email><xref rid="aff-4" ref-type="aff">4</xref></contrib><contrib id="author-7" contrib-type="author" corresp="yes"><name><surname>Redwan</surname><given-names>Elrashdy M.</given-names></name><email>lradwan@kau.edu.sa</email><xref rid="aff-1" ref-type="aff">1</xref><xref rid="aff-5" ref-type="aff">5</xref></contrib><aff id="aff-1"><label>1</label><institution>Department of Biological Sciences, Faculty of Science, King Abdulaziz University</institution>, <city>Jeddah</city>, <country>Saudi Arabia</country></aff><aff id="aff-2"><label>2</label><institution>Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo</institution>, <city>Sarajevo</city>, <country>Bosnia and Herzegovina</country></aff><aff id="aff-3"><label>3</label><institution>Autlan Regional Hospital, Jalisco Health Services</institution>, <city>Jalisco</city>, <country>Mexico</country></aff><aff id="aff-4"><label>4</label><institution>Department of Molecular Medicine and USF Health Byrd Alzheimer&#x02019;s Research Institute, Morsani College of Medicine, University of South Florida</institution>, <city>Tampa</city>, <state>FL</state>, <country>United States of America</country></aff><aff id="aff-5"><label>5</label><institution>Therapeutic and Protective Proteins Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications</institution>, <city>New Borg EL-Arab</city>, <state>Alexandria</state>, <country>Egypt</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Nakai</surname><given-names>Kenta</given-names></name></contrib></contrib-group><pub-date pub-type="epub"><day>20</day><month>5</month><year iso-8601-date="2025">2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>e19429</elocation-id><history><date date-type="received" iso-8601-date="2024-08-09"><day>9</day><month>8</month><year iso-8601-date="2024">2024</year></date><date date-type="accepted" iso-8601-date="2025-04-15"><day>15</day><month>4</month><year iso-8601-date="2025">2025</year></date></history><permissions><copyright-statement>&#x000a9;2025 Eltayeb et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Eltayeb et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions><self-uri xlink:href="https://peerj.com/articles/19429"/><abstract><p>COVID-19, caused by the SARS-CoV-2, poses significant global health challenges. A key player in its pathogenesis is the nucleocapsid protein (NP), which is crucial for viral replication and assembly. While NPs from other coronaviruses, such as SARS-CoV and MERS-CoV, are known to increase inflammation and cause acute lung injury, the specific effects of the SARS-CoV-2 NP on host cells remain largely unexplored. Recent findings suggest that the NP acts as a pathogen-associated molecular pattern (PAMP) that binds to Toll-like receptor 2 (TLR2), activating NF-<italic toggle="yes">&#x003ba;</italic>B (nuclear factor kappa-light-chain-enhancer of activated B cells) and MAPK (mitogen-activated protein kinase) signaling pathways. This activation is particularly pronounced in severe COVID-19 cases, leading to elevated levels of soluble ICAM-1 (intercellular adhesion molecule 1) and VCAM-1 (vascular cell adhesion molecule 1), which contribute to endothelial dysfunction and multiorgan damage. Furthermore, the NP is implicated in hyperinflammation and thrombosis&#x02014;key factors in COVID-19 severity and long COVID. Its potential to bind with MASP-2 (mannan-binding lectin serine protease 2) may also be linked to persistent symptoms in long COVID patients. Understanding these mechanisms, particularly the role of the NP in thrombosis, is essential for developing targeted therapies to manage both acute and chronic effects of COVID-19 effectively. This comprehensive review aims to elucidate the multifaceted roles of the NP, highlighting its contributions to viral pathogenesis, immune evasion, and the exacerbation of thrombotic events, thereby providing insights into potential therapeutic targets for mitigating the severe and long-term impacts of COVID-19.</p></abstract><kwd-group kwd-group-type="author"><kwd>SARS-CoV-2</kwd><kwd>Endothelial cells</kwd><kwd>Nucleocapsid protein</kwd><kwd>Long COVID</kwd><kwd>Thrombosis</kwd></kwd-group><funding-group><funding-statement>The authors received no funding for this work.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>A deadly coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) emerged for the first time in December&#x000a0;2019. It resulted in the coronavirus disease 2019 pandemic (COVID-19), an acute respiratory infection that posed a worldwide health threat (<xref rid="ref-60" ref-type="bibr">Hu et al., 2021</xref>). From its origin, SARS-CoV-2 has been a subject of a giant array of studies covering a wide spectrum of topic areas, including research on the signalosome (<xref rid="ref-83" ref-type="bibr">Lundstrom et al., 2023a</xref>), treatment strategies (<xref rid="ref-84" ref-type="bibr">Lundstrom et al., 2023b</xref>), and its possible relevance to other illnesses (<xref rid="ref-58" ref-type="bibr">Hromi&#x00107;-Jahjefendi&#x00107; et al., 2022</xref>; <xref rid="ref-59" ref-type="bibr">Hromi&#x00107;-Jahjefendi&#x00107; et al., 2023</xref>; <xref rid="ref-49" ref-type="bibr">Golzardi et al., 2024</xref>). The virus can spread through multiple routes, including oral transmission, but the main mode of transmission is through expired droplets and aerosols from humans (<xref rid="ref-8" ref-type="bibr">Berentschot et al., 2024</xref>; <xref rid="ref-6" ref-type="bibr">Ballouz et al., 2023</xref>; <xref rid="ref-43" ref-type="bibr">Franco et al., 2024</xref>; <xref rid="ref-11" ref-type="bibr">Brodin, 2021</xref>). The SARS-CoV-2, when infects humans, causes a disease commonly referred to as &#x0201c;COVID-19,&#x0201d; which can manifest as anything from no symptoms to pneumonia, with the most severe outcome of COVID-19 being respiratory failure and/or cytokine storm resulting in death. The initial pathological changes induced by the virus are caused by its ability to bind to the ACE-2 (angiotensin-converting enzyme 2) receptor abundantly expressed on endothelial cells, which allows it to enter these cells and replicate. Approximately 60% of individuals infected with the virus seem to have cleared it from their system after 28 days and are able to return to their usual activities. Nonetheless, over 40% of people have several kinds of post-COVID complications, such as the one termed as &#x0201c;long COVID-19&#x0201d;.</p><p>Thrombosis has emerged as a significant complication of COVID-19, characterized by an increased incidence of both venous thromboembolism (VTE) and arterial thromboses. The pathophysiology of COVID-19-associated thrombosis involves complex interactions between the immune response, endothelial dysfunction, and the coagulation cascade, leading to a prothrombotic state that can result in severe clinical outcomes (<xref rid="ref-91" ref-type="bibr">Mizurini et al., 2021</xref>). Patients with COVID-19 often exhibit elevated levels of D-dimer (a dimer of small fibrin protein fragments present in the blood after a blood clot is degraded by fibrinolysis) and other biomarkers indicative of coagulopathy, which correlate with disease severity (<xref rid="ref-51" ref-type="bibr">Gorog et al., 2022</xref>). Despite the extensive research on thrombosis in COVID-19, gaps remain in understanding the long-term implications of these thrombotic events, particularly in relation to long COVID. Many individuals experience persistent symptoms following recovery, suggesting that the mechanisms underlying thrombotic complications may contribute to these ongoing health issues (<xref rid="ref-71" ref-type="bibr">Knight et al., 2022</xref>).</p><p>At the molecular level, when a cell is infected with SARS-CoV-2, the virus hijacks the cell&#x02019;s mitochondrial function. Impairment of normal mitochondrial function results in the cytosolic accumulation of mitochondrial DNA, reflecting breakdown of the mitochondrial integrity. This type of DNA triggers the activation of inflammasomes and suppresses both innate and adaptive immunity within the body. Immunothrombosis is believed to play a significant role in COVID-19-associated coagulopathy (CAC) and the thrombogenic nature of COVID-19. This process is influenced by endothelial dysfunction, innate immune cell activation, NETosis (a cell death pathway involving formation of neutrophil extracellular traps (NETs)), platelet and complement activation, and the coagulation system.</p><p>A main player in COVID-19 pathogenesis is the nucleocapsid protein, which is crucial for viral replication and assembly. The nucleocapsid protein (NP) and viral RNA enter the host cell after infection to aid in replication and initiate the process of virus particle assembly and release (<xref rid="ref-96" ref-type="bibr">Narayanan et al., 2003</xref>). The virus infects cells expressing the ACE-2 enzyme on their plasma membrane, hijacks the cells&#x02019; synthetic macromolecules, and rapidly replicates and sheds. An individual infected with the virus may not show symptoms for the first 2&#x02013;3 days, despite high levels of replication and shedding. Such individuals are termed &#x0201c;asymptomatic spreaders&#x0201d; (<xref rid="ref-11" ref-type="bibr">Brodin, 2021</xref>). Following that the host&#x02019;s immune cells attack infected cells, releasing autacoids that cause symptoms such as cough, fever, and headache.</p><p>This review paper aims to explore the role of the nucleocapsid protein in platelet function related to COVID-19 and its post-acute sequelae, while also highlighting potential areas for future research. It is intended for researchers, clinicians, and healthcare professionals focused on the investigation and management of COVID-19 and its lingering complications.</p></sec><sec><title>Survey Methodology</title><p>We performed a literature review utilizing the PubMed database. Our search method included important phrases such as &#x0201c;SARS-CoV-2,&#x0201d; &#x0201c;COVID-19,&#x0201d; &#x0201c;Nucleocapsid protein,&#x0201d; &#x0201c;Platelet function,&#x0201d; &#x0201c;Immunothrombosis,&#x0201d; &#x0201c;Long COVID,&#x0201d; and &#x0201c;Coagulopathy&#x0201d; utilizing Boolean operators. We considered in total 157 peer-reviewed original research papers, reviews, and clinical trials published between December 2019 and the present (2024), limiting our selection to English-language literature. Articles were chosen based on their relevance to the role of the nucleocapsid protein in platelet function and its implications for COVID-19 development and post-acute complications. Non-peer-reviewed publications, editorials, opinion pieces, and conference abstracts were eliminated to ensure rigor. Data extraction entailed carefully assembling study objectives, techniques, findings, and conclusions, with a focus on quality and relevance. This strategy aims to give a full, up-to-date understanding of NP function in COVID-19.</p></sec><sec><title>The Nucleocapsid Protein</title><p>The genetic code of SARS-CoV-2 is composed of around 30,000 nucleotides that specify the production of four key structural proteins: the S, E, M, and NP (<xref rid="ref-82" ref-type="bibr">Lu et al., 2020</xref>). Of the four structural proteins, the NP is particularly immunogenic and is expressed in large quantities during infection. According to serological studies, NP antibodies in the blood plasma of COVID-19 patients are more sensitive and durable than antibodies against other structural proteins from SARS-CoV (<xref rid="ref-117" ref-type="bibr">Shi et al., 2003</xref>; <xref rid="ref-132" ref-type="bibr">Tan et al., 2004</xref>). Additionally, it has been documented that anti-N antibodies can be detected with great specificity in the early stages of infection (<xref rid="ref-74" ref-type="bibr">Leung et al., 2004</xref>; <xref rid="ref-75" ref-type="bibr">Li &#x00026; Li, 2021</xref>). After infection, the viral RNA penetrates the host cell accompanied by the NP, which facilitates genome encasing and assembly, viral particle replication, and the emergence of newly generated virions (<xref rid="ref-96" ref-type="bibr">Narayanan et al., 2003</xref>; <xref rid="ref-153" ref-type="bibr">Zinzula et al., 2021</xref>).</p><p>There are three highly conserved regions in the SARS-CoV-2 NP. An intrinsically disordered region (IDR, <italic toggle="yes">i.e.,</italic>&#x000a0;region that does not have a unique structure but plays a number crucial functional roles) (residues 175-246) that contains an SR-rich domain (SRD, residues 176-206) connects the two of the ordered domains, the N-terminal domain (NTD, residues 48-174) responsible for RNA binding and the C-terminal domain (CTD, residues 247-364), which mediates oligomerization and also binds RNA (<xref rid="ref-61" ref-type="bibr">Huang et al., 2004</xref>; <xref rid="ref-62" ref-type="bibr">Hurst, Koetzner &#x00026; Masters, 2009</xref>; <xref rid="ref-23" ref-type="bibr">Cong et al., 2020</xref>). SRD is particularly important, since it is the location of post-translational modifications, specifically phosphorylation (<xref rid="ref-44" ref-type="bibr">Fung &#x00026; Liu, 2018</xref>). Moreover, arginine residues R95 and R177 are methylated, which is an important step in the viral packaging of SARS-CoV-2 (<xref rid="ref-12" ref-type="bibr">Cai et al., 2021</xref>). <xref rid="fig-1" ref-type="fig">Figure 1</xref> shows some of the structural and functional features of the NP and illustrates that this protein contains more than an eye can see. Here, <xref rid="fig-1" ref-type="fig">Fig. 1A</xref> represents the per-residue intrinsic disorder profile of the SARS-CoV-2 NP and shows that this protein contains high levels of predicted intrinsic disorder (<italic toggle="yes">i.e.,</italic> regions located above the disorder threshold of 0.5), possessing three highly disordered regions, the N-tail (residues 1-100, note that the C-terminal half of this disordered region covers 40% of the NTD as well), linker domain (residues 175-246), and C-tail (residues 365-419). In other words, &#x0223c;55% of this protein is predicted to be disordered. Importantly, these predictions are supported by the 3D structural model generated by AlphaFold, as <xref rid="fig-1" ref-type="fig">Fig. 1B</xref> clearly shows that a very significant part of this protein is modeled with low confidence (red segments) and does not contain elements of ordered secondary structure. However, oligomerization of the SARS-CoV-2 NP induces formation of a stable structure in its CTD. This is illustrated by <xref rid="fig-1" ref-type="fig">Fig. 1C</xref> representing the resulting structure that shows a compact, strongly interwoven dimer with a core four-stranded <italic toggle="yes">&#x003b2;</italic>-sheet that forms the majority of the dimer interface. The intrinsically disordered nature of the NP defines its multifunctionality and binding promiscuity. In fact, this protein interacts with various viral and host proteins to facilitate the SARS-CoV infection (see <xref rid="fig-1" ref-type="fig">Fig. 1D</xref>). Genome packaging is done together with the matrix protein (M protein). It also interacts with nonstructural protein 3 (NSP3) which allows it to participate in replication-transcription complexes where RNA replication and transcription happen (<xref rid="ref-23" ref-type="bibr">Cong et al., 2020</xref>; <xref rid="ref-143" ref-type="bibr">Ye et al., 2020</xref>; <xref rid="ref-153" ref-type="bibr">Zinzula et al., 2021</xref>). Additionally, even though NP is mainly found in the cytoplasm (<xref rid="ref-89" ref-type="bibr">McBride, Van Zyl &#x00026; Fielding, 2014</xref>), a portion of its copies can be localized in the nucleolus, which, together with ADP-ribosylation (<xref rid="ref-55" ref-type="bibr">Grunewald et al., 2018</xref>; <xref rid="ref-44" ref-type="bibr">Fung &#x00026; Liu, 2018</xref>), could allow it to have an effect on the cell cycle (<xref rid="ref-125" ref-type="bibr">Su et al., 2020</xref>).</p><fig position="float" id="fig-1"><object-id pub-id-type="doi">10.7717/peerj.19429/fig-1</object-id><label>Figure 1</label><caption><title>Structural and functional characterization of SARS-CoV-2 N protein.</title><p>(A) Per-residue intrinsic disorder profile generated for the SARS-CoV-2 N protein (UniProt ID: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/protein/P0DTC9" ext-link-type="uri">P0DTC9</ext-link>) generated by the RIDAO platform that assembles the outputs of several commonly used per-residue intrinsic disorder predictors in one plot (<xref rid="ref-27" ref-type="bibr">Dayhoff &#x00026; Uversky, 2022</xref>). In addition to showing the outputs of PONDR<sup>&#x000ae;</sup> VLXT, PONDR<sup>&#x000ae;</sup> VL3, PONDR<sup>&#x000ae;</sup> VSL2, PONDR<sup>&#x000ae;</sup> FIT, IUPred_long and IUPred_short, RIDAO represents the mean disorder profile (MDP), which is calculated by averaging the disorder profiles of individual predictors. The light pink shade represents the MDP error distribution. The thin black line at the disorder score of 0.5 is the threshold between order and disorder, where residues/regions above 0.5 are disordered, and residues/regions below 0.5 are ordered. The dashed line at the disorder score of 0.15 is the threshold between order and flexibility, where residues/regions above 0.15 are flexible, and residues/regions below 0.15 are highly ordered. (B) 3D structure of the full-length protein modeled by AlphaFold (<xref rid="ref-68" ref-type="bibr">Jumper et al., 2023</xref>). Regions with low per-residue confidence scores (red) are expected to be disordered in isolation, whereas the two known domains are predicted with a high confidence (blue). (C) 3D structure of the dimeric form of the CTD of SARS-CoV-2 nucleocapsid protein (residues 247-364) (PDB: 6WZO) generated using PyMol (<xref rid="ref-115" ref-type="bibr">Schr&#x000f6;dinger, 2015</xref>; <xref rid="ref-143" ref-type="bibr">Ye et al., 2020</xref>). (D) Protein-protein interaction network centered at the SARS-CoV-2 N protein. This network was generated by IntAct, which is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions (<xref rid="ref-101" ref-type="bibr">Orchard et al., 2014</xref>). The network represents both viral and host proteins with established physical associations.</p></caption><graphic xlink:href="peerj-13-19429-g001" position="float"/></fig></sec><sec><title>The Role of Nucleocapsid Protein in SARS-CoV-2 Life Cycle</title><sec><title>Viral core formation</title><p>SARS-CoV-2 viral RNA synthesis and packaging are encoded by its genomic RNA (gRNA) that has a length around 30 kb long. This gRNA encodes the structural proteins mentioned before. NP, as a very commonly found structural protein in infected cells by COVID-19 is located in the core component of the virus (<xref rid="ref-4" ref-type="bibr">Bai et al., 2021</xref>). This protein is essential for virus replication, evading host immunity, and virus maturation (<xref rid="ref-89" ref-type="bibr">McBride, Van Zyl &#x00026; Fielding, 2014</xref>; <xref rid="ref-105" ref-type="bibr">Peng et al., 2020</xref>; <xref rid="ref-124" ref-type="bibr">Stuwe et al., 2024</xref>). Additionally, one of the primary roles of the NP is to bind, condense, and package the viral genome. It does this by wrapping the viral RNA into structures called nucleocapsids or capsids, which are flexible, elongated, helical complexes made of ribonucleoprotein (RNP) (<xref rid="ref-151" ref-type="bibr">Zhao et al., 2021b</xref>; <xref rid="ref-141" ref-type="bibr">Wu et al., 2023</xref>; <xref rid="ref-124" ref-type="bibr">Stuwe et al., 2024</xref>). The nucleocapsid shields the genome and guarantees its punctual replication and consistent dissemination. The elongated nucleocapsids, with diameters ranging from 10 to 15 nm and lengths of several hundred nanometers, can be seen with an electron microscope (<xref rid="ref-29" ref-type="bibr">De Haan &#x00026; Rottier, 2005</xref>). NP-RNA interactions and intermolecular relationships between disulfide-linked NP multimers occur within the nucleocapsid (<xref rid="ref-110" ref-type="bibr">Robbins et al., 1986</xref>). The interaction between the NP and RNA is facilitated by binding signals present in the leader RNA sequences (<xref rid="ref-7" ref-type="bibr">Baric et al., 1988</xref>). In the course of the virus&#x02019;s life cycle, several NP molecules interact with both gRNA and subgenomic RNA (sgRNA), implying a function for the NP in the transcription and translation of the virus (<xref rid="ref-7" ref-type="bibr">Baric et al., 1988</xref>; <xref rid="ref-97" ref-type="bibr">Narayanan, Kim &#x00026; Makino, 2003</xref>). The fundamental unit for the formation of coronaviruses (CoV) nucleocapsids is a dimeric structure composed of NP (<xref rid="ref-39" ref-type="bibr">Fan et al., 2005</xref>), with the C-terminal dimerization domain (CTD) of the NP providing the ability to dimerize (<xref rid="ref-130" ref-type="bibr">Surjit et al., 2004</xref>). A study found that structural analysis shows the NP is present not only in the helical nucleocapsid but also in the inner spherical or icosahedral core (<xref rid="ref-109" ref-type="bibr">Risco et al., 1996</xref>). RNA, the CTD of the M protein, and the NP are only a few of the vital elements that are located inside the virus&#x02019;s internal core and work together to sustain healthy viral functioning. Most of the core&#x02013;shell, or M protein, binds to the NP by an ionic interaction with a specific 16 amino acid region (aa 237&#x02013;252) on its CTD. This enables the exact assembly of the genetic material within the growing viral particle (<xref rid="ref-109" ref-type="bibr">Risco et al., 1996</xref>; <xref rid="ref-38" ref-type="bibr">Escors et al., 2001</xref>; <xref rid="ref-72" ref-type="bibr">Kuo &#x00026; Masters, 2002</xref>). Consequently. The NP is necessary for the CoV virion to assemble because of its interactions with the M protein, the genomic RNA, and other NP.</p></sec><sec><title>Viral assembly</title><p>The creation of viral particles is an important stage in ensuring the virus&#x02019;s successful reproduction cycle. Within the viral envelope of CoV virions, there is a viral nucleocapsid consisting of gRNA and NP, along with three envelope proteins, envelope (E), membrane (M), and spike (S). The assembly process of CoV virions requires several steps, including the dimerization of CoV NP (<xref rid="ref-56" ref-type="bibr">He et al., 2004</xref>; <xref rid="ref-130" ref-type="bibr">Surjit et al., 2004</xref>; <xref rid="ref-149" ref-type="bibr">Yu et al., 2005</xref>) and its association with viral gRNA to form RNPs (<xref rid="ref-85" ref-type="bibr">Macnaughton, Davies &#x00026; Nermut, 1978</xref>; <xref rid="ref-26" ref-type="bibr">Davies, Dourmashkin &#x00026; Macnaughton, 1981</xref>; <xref rid="ref-7" ref-type="bibr">Baric et al., 1988</xref>; <xref rid="ref-109" ref-type="bibr">Risco et al., 1996</xref>; <xref rid="ref-100" ref-type="bibr">Nelson, Stohlman &#x00026; Tahara, 2000</xref>; <xref rid="ref-19" ref-type="bibr">Chen et al., 2005</xref>), interactions between the four structural proteins, and the acquisition of a host membrane envelope from the site of budding. Through the use of endoplasmic reticulum (ER)-Golgi intermediate compartment membranes, nucleocapsid budding produces the lipid envelope of CoVs (<xref rid="ref-28" ref-type="bibr">De Haan et al., 1998</xref>; <xref rid="ref-30" ref-type="bibr">De Haan et al., 1999</xref>). The integration of the nucleocapsid in enveloped viruses is thought to depend on the connection between the nucleocapsid and envelope proteins (<xref rid="ref-127" ref-type="bibr">Suomalainen, Liljestr&#x000f6;m &#x00026; Garoff, 1992</xref>), and this has been observed in alphaviruses since such interactions between proteins are essential for viral assembly (<xref rid="ref-127" ref-type="bibr">Suomalainen, Liljestr&#x000f6;m &#x00026; Garoff, 1992</xref>; <xref rid="ref-79" ref-type="bibr">Lopez et al., 1994</xref>).</p><p>In CoV virions, the N and M proteins are the most significant structural proteins (<xref rid="ref-123" ref-type="bibr">Sturman, Holmes &#x00026; Behnke, 1980</xref>; <xref rid="ref-98" ref-type="bibr">Narayanan et al., 2000</xref>). The M protein&#x02019;s three transmembrane domains anchor it to the viral envelope, while its sizable carboxy-terminal tail in the virion interior engages with the nucleocapsid (<xref rid="ref-98" ref-type="bibr">Narayanan et al., 2000</xref>). Positive-strand gRNA and mRNA 1 in the nucleocapsid are helically enveloped by NPs. The N-M protein interaction at the C-terminus seems unique to CoVs.</p></sec><sec><title>Replication of genomic mRNA and synthesis of gRNA</title><p>In order to obtain a successful viral replication, the degradation of the virus genome <italic toggle="yes">via</italic> RNA interference as an inherent antiviral immune defense by the host should be inhibited (<xref rid="ref-93" ref-type="bibr">Mu et al., 2020</xref>; <xref rid="ref-4" ref-type="bibr">Bai et al., 2021</xref>; <xref rid="ref-141" ref-type="bibr">Wu et al., 2023</xref>). NP functions as an RNA interference inhibitor and it mediates the synthesis of gRNA (<xref rid="ref-23" ref-type="bibr">Cong et al., 2020</xref>; <xref rid="ref-12" ref-type="bibr">Cai et al., 2021</xref>; <xref rid="ref-142" ref-type="bibr">Xu et al., 2021</xref>). The NP has the ability to attach to both the complete gRNA and all sgRNAs, with a stronger attraction towards the gRNA (<xref rid="ref-22" ref-type="bibr">Cologna &#x00026; Hogue, 1998</xref>). The gRNA serves as both a blueprint for the viral RNA-dependent RNA polymerase and a messenger for translation (<xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>). In infection, gRNA is transcribed into negative-stranded RNA, then full-length gRNA that attaches to polysomes (<xref rid="ref-10" ref-type="bibr">Brayton et al., 1982</xref>) and is observed in nucleocapsids (<xref rid="ref-119" ref-type="bibr">Spaan et al., 1981</xref>). A large number of studies have indicated that optimal CoV replication requires the presence of the NP (<xref rid="ref-146" ref-type="bibr">Yount, Curtis &#x00026; Baric, 2000</xref>; <xref rid="ref-134" ref-type="bibr">Thiel et al., 2001</xref>; <xref rid="ref-14" ref-type="bibr">Casais et al., 2001</xref>; <xref rid="ref-148" ref-type="bibr">Yount et al., 2002</xref>; <xref rid="ref-147" ref-type="bibr">Yount et al., 2003</xref>; <xref rid="ref-2" ref-type="bibr">Almaz&#x000e1;n, Gal&#x000e1;n &#x00026; Enjuanes, 2004</xref>; <xref rid="ref-114" ref-type="bibr">Schelle et al., 2005</xref>; <xref rid="ref-154" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2010</xref>). The implication that the N protein plays a role in an early stage of RNA synthesis is supported by two observations: first, the colocalization of mouse hepatitis virus (MHV) and SARS-CoV NPs with replicase components inside cells at the beginning of infection (<xref rid="ref-31" ref-type="bibr">Denison et al., 1999</xref>; <xref rid="ref-137" ref-type="bibr">Van Der Meer et al., 1999</xref>; <xref rid="ref-118" ref-type="bibr">Sims, Ostermann &#x00026; Denison, 2000</xref>; <xref rid="ref-121" ref-type="bibr">Stertz et al., 2007</xref>), and second, the dependence of gRNA infection stimulation on NP translation (<xref rid="ref-88" ref-type="bibr">Masters et al., 1994</xref>; <xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>).</p><p>It has been shown that the regulation of phosphorylation of the SR-rich region (serine/arginine rich) of NP could affect viral replication and transcription (<xref rid="ref-9" ref-type="bibr">Bouhaddou et al., 2020</xref>; <xref rid="ref-77" ref-type="bibr">Liu et al., 2021</xref>; <xref rid="ref-13" ref-type="bibr">Carlson et al., 2022</xref>; <xref rid="ref-21" ref-type="bibr">Cheng et al., 2023</xref>). A clearer role for NP in gRNA synthesis was established when an interaction between MHV NP&#x02019;s SR region and nsp3 subunit&#x02019;s amino terminal segment was found (<xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>; <xref rid="ref-70" ref-type="bibr">Keane &#x00026; Giedroc, 2013</xref>). The interaction between N and nsp3 has been precisely located in the ubiquitin-like domain (Ubl1) of nsp3, a crucial domain for the virus (<xref rid="ref-63" ref-type="bibr">Hurst, Koetzner &#x00026; Masters, 2013</xref>). Furthermore, it has been established that the N-nsp3 interaction is essential for the NP to effectively increase the infectivity of gRNA (<xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>). It has been put forth that NP links gRNA to replicase <italic toggle="yes">via</italic> nsp3 interaction for initiation complex development at the genome&#x02019;s 3&#x02032;&#x000a0; end (<xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>; <xref rid="ref-63" ref-type="bibr">Hurst, Koetzner &#x00026; Masters, 2013</xref>). Given that negative-strand synthesis initiation is the initial step in both genomic replication and transcription (<xref rid="ref-113" ref-type="bibr">Sawicki, Sawicki &#x00026; Siddell, 2007</xref>; <xref rid="ref-156" ref-type="bibr">Z&#x000fc;st et al., 2008</xref>), the N-nsp3 interaction is likely significant in both RNA-synthetic processes (<xref rid="ref-64" ref-type="bibr">Hurst et al., 2010</xref>). The involvement of the NP in MHV gRNA synthesis may not be restricted to the early phases of infection, as it has been proposed that the NP supports ongoing transcription for the duration of the infection (<xref rid="ref-54" ref-type="bibr">Graham &#x00026; Denison, 2006</xref>; <xref rid="ref-154" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2010</xref>). The contribution of the CoV NP to RNA synthesis is still disputed, as it&#x02019;s not indispensable for transmissible gastroenteritis coronavirus RNA replication, but it plays a significant role in efficient transcription (<xref rid="ref-154" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2010</xref>).</p></sec><sec><title>Chaperone activity</title><p>RNA chaperone proteins provide assistance in ensuring the correct folding of nucleic acid molecules (<xref rid="ref-57" ref-type="bibr">Herschlag, 1995</xref>; <xref rid="ref-24" ref-type="bibr">Cristofari &#x00026; Darlix, 2002</xref>). It has been suggested that chaperone activity is a common feature of all CoV NPs, as evidenced by the demonstration of this activity in transmissible gastroenteritis coronavirus and SARS-CoV NPs (<xref rid="ref-155" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2007</xref>). Chaperone activity and <italic toggle="yes">in vitro</italic> template switching facilitation are proposed for amino acids 117-268 of transmissible gastroenteritis coronavirus NP&#x02019;s linker <italic toggle="yes">region</italic> domain (<xref rid="ref-155" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2007</xref>; <xref rid="ref-154" ref-type="bibr">Z&#x000fa;&#x000f1;iga et al., 2010</xref>). It has been demonstrated that NP increases RNA synthesis; this effect may be attributed to the protein&#x02019;s ability to facilitate template switching, which is necessary for effective transcription.</p></sec><sec><title>Cell cycle regulation</title><p>The exploitation of host cell machinery through the deregulation of the cell cycle is a frequently used tactic by many RNA and DNA viruses to create a more favorable environment for their survival. The MHV nonstructural protein, p28, is known to cause G0/G1 cell cycle arrest by preventing the hyperphosphorylation of retinoblastoma protein (Rb), a crucial step for the progression of the cell cycle from late G1 into the S phase (<xref rid="ref-65" ref-type="bibr">Ikeda et al., 1998</xref>; <xref rid="ref-17" ref-type="bibr">Chen &#x00026; Makino, 2004</xref>). A model suggests that the expression of cytoplasmic p28 leads to the stabilization of cellular tumor antigen p53, and the subsequent accumulation of p53 results in the transcriptional upregulation of p21, a cyclin-dependent kinase (CDK) inhibitor. This, in turn, suppresses cyclin E/CDK 2 activities and reduces G1 cyclin-CDK complexes and CDK activities, ultimately inhibiting Rb hyperphosphorylation (<xref rid="ref-17" ref-type="bibr">Chen &#x00026; Makino, 2004</xref>). The NP of SARS-CoV regulates cyclin-CDK activity to modulate the host cell cycle, resulting in the halting of S-phase progression. The NP, which possesses a signature cyclin box-binding region (RXL motif), is capable of being phosphorylated by CDK and thus serves as a substrate for the cyclin-CDK complex (<xref rid="ref-128" ref-type="bibr">Surjit et al., 2005</xref>). The NP has been demonstrated to inhibit S-phase cyclins CDK4 and, to a lesser degree, CDK6 (<xref rid="ref-128" ref-type="bibr">Surjit et al., 2005</xref>). Kinase inhibition causes Rb to remain hypophosphorylated, preventing E2F1 release and halting S phase gene transcription (<xref rid="ref-65" ref-type="bibr">Ikeda et al., 1998</xref>). In a manner similar to MHV p28, the NP of SARS-CoV also inhibits CDK2 activity, which results in the blockage of both G1 and S phase cyclins. This means that the NP doubly ensures the prevention of S phase progression (<xref rid="ref-128" ref-type="bibr">Surjit et al., 2005</xref>). NP inhibits CDK activity, leading to Rb phosphorylation inhibition, independently of CDK inhibitors (CDKIs) like p21. NP is suggested to mimic CDKIs by competitively inhibiting CDK4 and CDK2 (<xref rid="ref-128" ref-type="bibr">Surjit et al., 2005</xref>). It has been suggested that the blocking of the S phase by p28 (MHV) and NP (SARS) allows these viruses sufficient time to use the cellular raw materials synthesized prior to the S phase for genome replication and assembly and budding of progeny particles (<xref rid="ref-129" ref-type="bibr">Surjit et al., 2006</xref>). The results obtained show that different proteins belonging to the CoV family can reduce the regulation of the cell cycle; in the case of the SARS-NP, multiple pathways can be used to do this.</p></sec></sec><sec><title>SARS-CoV-2 NP: Expression and Immunity</title><p>NP establishes a connection with viral RNA <italic toggle="yes">via</italic> electrostatic interactions, which results in the creation of virion particles consisting of cytoplasmic helical ribonucleoprotein complex (<xref rid="ref-33" ref-type="bibr">Di et al., 2021</xref>). These nucleocapsids subsequently associate with M, promoting the emergence of the virus into early secretory compartments. N, being the most profusely expressed protein of SARS-CoV-2, triggers potent Ab and TCD8+ immune responses (<xref rid="ref-78" ref-type="bibr">Long et al., 2020</xref>; <xref rid="ref-111" ref-type="bibr">Sariol &#x00026; Perlman, 2020</xref>; <xref rid="ref-80" ref-type="bibr">L&#x000f3;pez-Mu&#x000f1;oz et al., 2022</xref>).</p><p>The phenomenon of viral RNA- and DNA-binding proteins being expressed on the cell surface can be traced back to the initial detection of polyclonal Ab of retrovirus gag and polyoma virus T antigen in the 1970s (<xref rid="ref-32" ref-type="bibr">Deppert &#x00026; Henning, 1980</xref>). Contrary to the widespread assumption that CoV N is solely found in the cytoplasm, it&#x02019;s often observed that the cell surface expression of RNA virus&#x02019;s N is more common (<xref rid="ref-80" ref-type="bibr">L&#x000f3;pez-Mu&#x000f1;oz et al., 2022</xref>). Preliminary experiments using monoclonal Abs (mAbs) have documented the surface expression of influenza A and vesicular stomatitis virus N (<xref rid="ref-145" ref-type="bibr">Yewdell, Frank &#x00026; Gerhard, 1981</xref>; <xref rid="ref-144" ref-type="bibr">Yewdell et al., 1986</xref>). Influenza neuraminidase (N) protein, a significant component of the influenza virus, is susceptible to two specific types of lysis: Ab complement&#x02013;mediated cell lysis (<xref rid="ref-145" ref-type="bibr">Yewdell, Frank &#x00026; Gerhard, 1981</xref>) and Ab-redirected T cell lysis (<xref rid="ref-120" ref-type="bibr">Staerz, Yewdell &#x00026; Bevan, 1987</xref>). These processes contribute to the destruction of infected cells. Additionally, in the context of murine models (<xref rid="ref-73" ref-type="bibr">LaMere et al., 2011</xref>), Influenza N is specifically targeted by protective Abs, which play a crucial role in the immune response against the virus. This is relevant to SARS-CoV-2 because similar mechanisms of immune response and cell surface expression of the nucleocapsid protein have been observed. Research on the pure SARS-CoV-2 NP recombinant from bacterial cells demonstrates that it triggers an immune response in mouse and human mAbs (<xref rid="ref-35" ref-type="bibr">Djukic et al., 2021</xref>; <xref rid="ref-33" ref-type="bibr">Di et al., 2021</xref>; <xref rid="ref-75" ref-type="bibr">Li &#x00026; Li, 2021</xref>).</p><p>Studies on viral infections in humans have shown that N and N-like RNA genome binding proteins are expressed on the surface of infected cells. Included in this group of viruses are the lymphocytic choriomeningitis virus (<xref rid="ref-122" ref-type="bibr">Straub et al., 2013</xref>), the HIV virus (<xref rid="ref-66" ref-type="bibr">Ikuta et al., 1989</xref>), measles (<xref rid="ref-87" ref-type="bibr">Marie et al., 2004</xref>), and the respiratory syncytial virus (<xref rid="ref-15" ref-type="bibr">C&#x000e9;spedes et al., 2014</xref>). This can be also applied to the NP from SARS-CoV-2 (<xref rid="ref-80" ref-type="bibr">L&#x000f3;pez-Mu&#x000f1;oz et al., 2022</xref>), which can regulate chemokine synthesis (<xref rid="ref-81" ref-type="bibr">L&#x000f3;pez-Mu&#x000f1;oz, Santos &#x00026; Yewdell, 2023</xref>). Research findings have revealed that the immune system response can be negatively impacted by NP expression on the cell surface. In particular, it was discovered to block immune synapses located on T cells, which are essential for effective immune responses. In addition, it can suppress Il-12 release, an important cytokine engaged in immunological signaling (<xref rid="ref-87" ref-type="bibr">Marie et al., 2004</xref>; <xref rid="ref-15" ref-type="bibr">C&#x000e9;spedes et al., 2014</xref>).</p><p>Studies conducted on the NP of SARS-CoV-2 have demonstrated that it significantly affects the outcomes of both innate and adaptive immunity. It inhibits the expression of type I and type III interferons. Specifically, it inhibits the IFN-<italic toggle="yes">&#x003b2;</italic> (interferon beta), NF-<italic toggle="yes">&#x003ba;</italic>B, and IFN-<italic toggle="yes">&#x003bb;</italic>1 (interferon lambda 1) promoter activities (<xref rid="ref-16" ref-type="bibr">Chang et al., 2020</xref>; <xref rid="ref-76" ref-type="bibr">Li et al., 2020</xref>), and inhibits the interaction between retinoic acid-inducible gene I (RIG-I) and tripartite motif protein 25 (TRIM25) (<xref rid="ref-152" ref-type="bibr">Zhao et al., 2021a</xref>; <xref rid="ref-92" ref-type="bibr">Mohd Faizal et al., 2023</xref>). Additionally, NP increases the viability of infected cells by demonstrating an anti-apoptotic action <italic toggle="yes">via</italic> modifying the <italic toggle="yes">BAX</italic> (apoptosis regulator BAX) and <italic toggle="yes">BCL-2</italic> (apoptosis regulator BCL-2) genes (<xref rid="ref-36" ref-type="bibr">Edalat et al., 2024</xref>).</p><p>The NP has the ability to control nuclear translocation and phosphorylation of IRF3 (interferon regulatory factor 3), STAT1 (signal transducer and activator of transcription 1), and STAT2 (<xref rid="ref-152" ref-type="bibr">Zhao et al., 2021a</xref>). Moreover, it has been shown that NP has a high-affinity interaction with more than 10 human chemokines, including CXCL12<italic toggle="yes">&#x003b2;</italic> (C-X-C motif chemokine, 12 also known as stromal cell-derived factor 1, SDF-1). This is an important mechanism by which the chemotaxis of leukocytes, normally performed by CXCL12<italic toggle="yes">&#x003b2;</italic> is inhibited (<xref rid="ref-81" ref-type="bibr">L&#x000f3;pez-Mu&#x000f1;oz, Santos &#x00026; Yewdell, 2023</xref>). It has also been shown that SARS-CoV-2 NP leads to the overexpression of proinflammatory cytokines in general, including IL-6 (interleukin 6), IL-12, IL-1<italic toggle="yes">&#x003b2;</italic>, and TNF-<italic toggle="yes">&#x003b1;</italic> (tumor necrosis factor alpha) (<xref rid="ref-36" ref-type="bibr">Edalat et al., 2024</xref>), as well as the triggering of cytokine storm in lung epithelial cells specifically (<xref rid="ref-139" ref-type="bibr">Wang et al., 2024</xref>). One of the ways a proinflammatory response can happen is through the interaction with 14-3-3 human isoforms (all seven of them); a group of proteins important for different types of signaling in cells, including the modulation of the inflammatory response (<xref rid="ref-94" ref-type="bibr">Munier, Ottmann &#x00026; Perry, 2021</xref>; <xref rid="ref-135" ref-type="bibr">Tugaeva et al., 2021</xref>).</p></sec><sec><title>The Dormant Endothelial Layer</title><p>A monolayer of cobblestone-shaped endothelial cells that are placed at the inner lining of blood vessels and act as a link between the circulatory system and organ-specific tissues forms the endothelium (<xref rid="ref-107" ref-type="bibr">Pober &#x00026; Sessa, 2007</xref>; <xref rid="ref-106" ref-type="bibr">Perico, Benigni &#x00026; Remuzzi, 2024</xref>). To comprehend the role of the endothelium in the vascular complications of COVID-19, it&#x02019;s essential to first understand its functions in normal physiology.</p><p>The endothelium is &#x0003c;0.2 &#x000b5;m thick and it is covering the central parts of the immune and vascular system (<xref rid="ref-140" ref-type="bibr">Wolinsky, 1980</xref>; <xref rid="ref-50" ref-type="bibr">Gomez-Salinero &#x00026; Rafii, 2018</xref>). The structure of the endothelial cells is different based on the tissue of the origin (<xref rid="ref-50" ref-type="bibr">Gomez-Salinero &#x00026; Rafii, 2018</xref>) and their function mostly includes maintenance of vascular homeostasis (<xref rid="ref-95" ref-type="bibr">Murakami et al., 2008</xref>), the control of vascular tone and blood flow (<xref rid="ref-25" ref-type="bibr">D&#x02019;Alessio, 2023</xref>), and serving as an anticoagulant surface and maintains barrier integrity (<xref rid="ref-138" ref-type="bibr">Van Hinsbergh, 2012</xref>). They also play a key role in immune surveillance, contributing to both adaptive and innate immunity (<xref rid="ref-86" ref-type="bibr">Mai et al., 2013</xref>; <xref rid="ref-116" ref-type="bibr">Shao et al., 2020</xref>). Specific inherent cytoprotective mechanisms and unique cellular features ensure the maintenance of endothelial dormancy.</p><p>A balanced condition of the environment in contact with endothelium leads to anticoagulant and non-thrombogenic cells (<xref rid="ref-40" ref-type="bibr">F&#x000e9;l&#x000e9;tou, 2011</xref>). However, any changes that cause activation of endothelial cells and production of macromolecules by them could potentially promote thrombus formation (<xref rid="ref-40" ref-type="bibr">F&#x000e9;l&#x000e9;tou, 2011</xref>). Endothelial activation, also known as endotheliopathy, has been reported as a consequence of the presence of SARS-CoV-2 particles (<xref rid="ref-133" ref-type="bibr">Teuwen et al., 2020</xref>; <xref rid="ref-52" ref-type="bibr">Goshua et al., 2020</xref>; <xref rid="ref-150" ref-type="bibr">Zhang et al., 2020</xref>; <xref rid="ref-99" ref-type="bibr">Nassar et al., 2021</xref>; <xref rid="ref-103" ref-type="bibr">Otifi &#x00026; Adiga, 2022</xref>; <xref rid="ref-106" ref-type="bibr">Perico, Benigni &#x00026; Remuzzi, 2024</xref>). Multiple evidence has shown that patients who were diagnosed with this dysfunction as a result of SARS-CoV-2 infection, developed endothelitis, hypercoagulation, and hypofibrinolysis (<xref rid="ref-136" ref-type="bibr">Valencia et al., 2024</xref>). Furthermore, the link between the severity of CoV-19 infection, disease mortality, and contributing to long-COVID syndrome and post-COVID sequela to endotheliopathy makes the understanding of this topic more crucial (<xref rid="ref-133" ref-type="bibr">Teuwen et al., 2020</xref>; <xref rid="ref-103" ref-type="bibr">Otifi &#x00026; Adiga, 2022</xref>; <xref rid="ref-106" ref-type="bibr">Perico, Benigni &#x00026; Remuzzi, 2024</xref>; <xref rid="ref-136" ref-type="bibr">Valencia et al., 2024</xref>).</p></sec><sec><title>Hyperinflammation and Thrombosis: The Link Between COVID-19, Long COVID, and the Nucleocapsid Protein</title><p>Coronaviruses from previous epidemics, specifically SARS-CoV and MERS-CoV, have been implicated in increasing the propensity for thrombosis (<xref rid="ref-48" ref-type="bibr">Giannis, Ziogas &#x00026; Gianni, 2020</xref>). Coagulopathy is a significant clinical symptom of COVID-19. The development of this complication involves various mechanisms such as damage to the endothelium, an excessive inflammatory response and cytokine storm, activation of the complement system, mononuclear phagocytes, formation of neutrophil extracellular traps (NETs), and tissue hypoxia (<xref rid="ref-90" ref-type="bibr">McFadyen, Stevens &#x00026; Peter, 2020</xref>; <xref rid="ref-1" ref-type="bibr">Abou-Ismail et al., 2020</xref>; <xref rid="ref-53" ref-type="bibr">Goswami et al., 2021</xref>).</p><p>The cytokine profile of patients with severe COVID-19 shows a rise in the production of TNF, IL-6, IL-7, and inflammatory chemokines including CCL3, CCL2, and soluble IL-2 receptors. These findings parallel those found in cytokine release syndrome (CRS), such as macrophage activation syndrome. Thrombosis can result from an overproduction of cytokines, which activate monocytes, neutrophils, and the endothelium, thereby promoting a prothrombotic state (<xref rid="ref-1" ref-type="bibr">Abou-Ismail et al., 2020</xref>). During proinflammatory conditions, IL-1<italic toggle="yes">&#x003b1;</italic>, expressed by activated platelets, endothelial cells, and monocytes, acts as a connector between the coagulation process and inflammation. Moreover, IL-1<italic toggle="yes">&#x003b1;</italic> contributes to thrombosis by extending clot lysis time, enhancing platelet function, and stimulating endothelial cells. The secretion of IL-1<italic toggle="yes">&#x003b1;</italic> by epithelial cells triggers the detection by inflammatory myeloid cells and inflammasome activation, leading to an intensified inflammatory cascade (<xref rid="ref-34" ref-type="bibr">Di Salvo et al., 2021</xref>). At the same time, endothelial cells expressing IL-1<italic toggle="yes">&#x003b1;</italic> trigger the attraction of granulocytes and thrombosis (<xref rid="ref-112" ref-type="bibr">Savla, Prabhavalkar &#x00026; Bhatt, 2021</xref>).</p><p>From a mechanistic standpoint, it&#x02019;s postulated that the NP of SARS-CoV-2 has the ability to bind to MASP-2 (mannan-binding lectin serine protease 2), a crucial component in the complement system (<xref rid="ref-46" ref-type="bibr">Gao et al., 2022</xref>). This interaction is believed to trigger the activation of the complement system, a key player in the body&#x02019;s immune response, thereby intensifying the injury to tissues. The subsequent activation of the complement pathway is associated with an increased production of various endothelial cytokines, including but not limited to IL-6, RANTES (T-cell-specific protein RANTES, also known as C-C motif chemokine 5, CCL5), IL-1, IL-8, and MCP-1 (monocyte chemoattractant protein 1, also known as C-C motif chemokine 2, CCL2). The body&#x02019;s inflammatory response is significantly influenced by these cytokines. In addition, the activation also leads to an upregulation in the expression of important endothelial adhesion molecules, specifically P-selectin and the von Willebrand factor, which are vital for cellular adhesion and thrombus formation (<xref rid="ref-42" ref-type="bibr">Foreman et al., 1994</xref>; <xref rid="ref-41" ref-type="bibr">Foley &#x00026; Conway, 2016</xref>).</p><p>Our previous review hypothesized that the SARS-CoV-2 NP might contribute to long COVID through mechanisms such as liquid-liquid phase separation (<xref rid="ref-37" ref-type="bibr">Eltayeb et al., 2024</xref>), potentially leading to persistent inflammation and thrombosis. This hypothesis is supported by the multifunctional nature of the NP, which interacts with various host proteins and modulates immune responses (<xref rid="ref-69" ref-type="bibr">Katsoularis et al., 2022</xref>) focused on respiratory endothelial activation rather than thrombosis (<xref rid="ref-20" ref-type="bibr">Chen et al., 2022</xref>). They demonstrated that the NP of SARS-CoV-2 activates endothelial cells <italic toggle="yes">via</italic> the TLR2/NF-<italic toggle="yes">&#x003ba;</italic>B and MAPK signaling pathways. While this study did not directly conclude on thrombosis, endothelial activation is a critical step in the pathway leading to thrombotic events. Similarly, <xref rid="ref-108" ref-type="bibr">Qian et al., (2021)</xref> provided insights into the endothelial activation induced by the SARS-CoV-2 NP. They found that the NP significantly activates human endothelial cells through TLR2-mediated signaling pathways. Although this study did not demonstrate thrombosis in human or animal models, endothelial activation is a known precursor to thrombosis, supporting the potential link between the NP and thrombotic events.</p><p>Additional evidence further supports the association between COVID-19 and thrombotic complications. A recent study reported a significant increase in the risk of deep vein thrombosis and pulmonary embolism following SARS-CoV-2 infection (<xref rid="ref-102" ref-type="bibr">Othman et al., 2024</xref>). This study underscores the heightened thrombotic risk associated with COVID-19, which may extend to long COVID. Furthermore, research has shown that long COVID is associated with persistent coagulation abnormalities, including thrombotic complications (<xref rid="ref-67" ref-type="bibr">Jenner et al., 2021</xref>). This highlights the importance of understanding the mechanisms by which SARS-CoV-2, particularly the NP, may contribute to these long-term effects. By integrating these findings, we provide a comprehensive overview of the potential mechanisms linking the SARS-CoV-2 NP to thrombosis and long COVID. Further research is needed to elucidate these mechanisms and confirm the direct role of the NP in thrombotic events.</p><p>In addition, another study on the nucleocapsid protein of SARS-CoV-2 demonstrated that it provokes hyperinflammation through the accumulation of intracellular Cl- in the respiratory epithelium, mediated by protein-protein interactions. The researchers delved into the mechanism by which the NP of SARS-CoV-2 instigates excessive inflammatory responses in respiratory epithelial cells. Their findings indicated that the NP interacts with SMAD3 (mothers against decapentaplegic homolog 3) and suppresses the expression of CFTR (cystic fibrosis transmembrane conductance regulator), leading to an elevation in intracellular Cl<sup>&#x02212;</sup> concentration. This, in turn, results in the phosphorylation of SGK1 (serum/glucocorticoid-regulated kinase 1, also known as serine/threonine-protein kinase SGK1) and triggers subsequent inflammatory responses (<xref rid="ref-20" ref-type="bibr">Chen et al., 2022</xref>).</p><p>Research conducted by <xref rid="ref-108" ref-type="bibr">Qian et al. (2021)</xref> determined several pathways related to NP and endothelial cells. The MAPK and NF-<italic toggle="yes">&#x003ba;</italic>B signaling pathways regulate the expression of ICAM-1 and VCAM-1 (<xref rid="ref-45" ref-type="bibr">Fust&#x000e9; et al., 2004</xref>). By performing Western blott analysis, they determined that NP treatment induced the phosphorylation of I<italic toggle="yes">&#x003ba;</italic>B kinases (IKKs), p65, I<italic toggle="yes">&#x003ba;</italic>B<italic toggle="yes">&#x003b1;</italic>, JNK (c-Jun N-terminal kinase 1, also known as mitogen-activated protein kinase 8), and p38 and caused I<italic toggle="yes">&#x003ba;</italic>B<italic toggle="yes">&#x003b1;</italic> degradation suggesting that NP activated JNK, p38, and NF-<italic toggle="yes">&#x003ba;</italic>B signal pathways in human endothelial cells (<xref rid="ref-108" ref-type="bibr">Qian et al., 2021</xref>). The same group determined NP-induced endothelial cell activation <italic toggle="yes">via</italic> the TLR2-mediated signaling pathway. It was shown that internalization of the NP is not required for endothelium activation, as indicated by the absence of impact from endocytosis inhibitors and NP overexpression within cells. The NP seems to interact with a cell surface receptor, most likely TLR2, as TLR2 antagonists, but not TLR4 or IL-1R, greatly reduced NP-induced ICAM-1 and VCAM-1 expression. Moreover, the research done by the same working group (<xref rid="ref-108" ref-type="bibr">Qian et al., 2021</xref>) observed that SARS-CoV-2&#x02019;s NP, but not those of other coronaviruses, significantly increased endothelial cell activation. Despite the substantial sequence similarity between SARS-CoV-2, SARS-CoV, and MERS-CoV, only SARS-CoV-2 causes major vascular damage and thrombosis. This difference is due to SARS-CoV-2&#x02019;s NP, which, unlike other viruses&#x02019; NPs, promotes endothelium activation. This result explains the significant vascular problems reported in COVID-19 patients (<xref rid="ref-108" ref-type="bibr">Qian et al., 2021</xref>).</p><p>While a significant proportion of individuals recover from the acute phase of COVID-19, a subset continues to experience symptoms for an extended period, often weeks or months after the initial infection. The enduring impacts of hyperinflammation and thrombosis, two critical aspects of severe COVID-19, are likely implicated in this syndrome. A particular article delves deeper into the potential role of the SARS-CoV-2 nucleocapsid protein in the development of long COVID, a condition where individuals continue to experience symptoms for more than 12 weeks after being infected with the virus. The authors highlight the fundamental studies conducted on the nucleocapsid protein, particularly its capacity to go through a mechanism known as liquid-liquid phase separation. They suggested that this unique property may contribute to the persistent inflammation and bothersome symptoms experienced by individuals with long COVID (<xref rid="ref-37" ref-type="bibr">Eltayeb et al., 2024</xref>).</p><p>Numerous research efforts have indicated that a lack of or minimal production of SARS-CoV-2 antibodies, along with other inadequate immune responses during the acute phase of COVID-19, can forecast the occurrence of long COVID after a period of 6&#x02013;7 months in patients, irrespective of whether they were hospitalized or not (<xref rid="ref-3" ref-type="bibr">Augustin et al., 2021</xref>; <xref rid="ref-5" ref-type="bibr">Ballering et al., 2022</xref>). The inadequate immune responses encompass a diminished baseline level of IgG (<xref rid="ref-3" ref-type="bibr">Augustin et al., 2021</xref>), spike-specific memory B cells and reduced quantities of receptor-binding domain (<xref rid="ref-47" ref-type="bibr">Garc&#x000ed;a-Abell&#x000e1;n et al., 2021</xref>), low peak values of spike-specific IgG, and decreased levels of nucleocapsid IgG (<xref rid="ref-47" ref-type="bibr">Garc&#x000ed;a-Abell&#x000e1;n et al., 2021</xref>). In patients with severe long COVID, a recent preprint emphasized the low or absent responses of CD8<sup>+</sup> T cells and CD4+ T cells (<xref rid="ref-131" ref-type="bibr">Talla et al., 2021</xref>). Furthermore, researchers found lower numbers of CD8<sup>+</sup> T cells expressing CD107a, a crucial marker of cytotoxic T cell activity, in another extensive investigation. Concurrently, there was a decline in the quantity of CD8<sup>+</sup> T cells that produced interferon-<italic toggle="yes">&#x003b3;</italic> specific to nucleocapsid. When these patients were contrasted with a control group of people who had contracted the virus but did not suffer the long-term consequences of long COVID, the results were notably clear in those suffering from severe long COVID (<xref rid="ref-104" ref-type="bibr">Peluso et al., 2021</xref>). The presence of high autoantibody levels in long COVID has been found to negatively correlate with the levels of protective COVID-19 antibodies. This indicates that patients with elevated autoantibody levels could be more susceptible to breakthrough infections (<xref rid="ref-126" ref-type="bibr">Su et al., 2022</xref>).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>This review has illustrated the critical role of the SARS-CoV-2 nucleocapsid (N) protein in COVID-19, based on an analysis of 149 selected studies. The NP is prevalent in coronaviruses and plays an essential role in viral replication and assembly. While NPs from SARS-CoV and MERS-CoV have been shown to increase inflammation and cause acute lung injury, the specific effects of the SARS-CoV-2 NP on host cells are still being explored. It has been recognized that the SARS-CoV-2 NP acts as a pathogen-associated molecular pattern (PAMP) that binds to Toll-like receptor 2 (TLR2) and activates the NF-<italic toggle="yes">&#x003ba;</italic>B and MAPK signaling pathways. SARS-CoV-2 infection activates CK2 and p38 MAPK, raising blood levels of soluble ICAM-1 and VCAM-1, especially in severe cases. This underscores the significance of the NP in endothelial activation, leading to extensive endothelial dysfunction and multiorgan damage reported in severe COVID-19 patients.</p><p>Conclusively, the nucleocapsid protein of SARS-CoV-2 has been pinpointed as a crucial element in the evolution of hyperinflammation and thrombosis, two significant determinants in the severity and persistent effects of COVID-19. Its potential to bind to MASP-2 and initiate liquid-liquid phase separation may be associated with the ongoing symptoms endured by those affected by long COVID. Further investigation and insight into the mechanisms implicated in this protein&#x02019;s interaction with the immune system could result in improved therapeutic approaches and management of both the immediate and long-term consequences of COVID-19. The research on the SARS-CoV-2 NP is marked by both controversies and promising new directions. Conflicting evidence about the effects of NP phosphorylation and mutations highlights the complexity of its role in the viral lifecycle. However, emerging perspectives on targeting the NP for diagnostics, vaccines, and therapeutics offer hope for more effective management of COVID-19 and its long-term effects. The highly conserved nature of the NP makes it a promising target for diagnostic tests and vaccines, potentially improving sensitivity and effectiveness. Furthermore, understanding how the NP modulates the immune response, such as its ability to inhibit the NF-<italic toggle="yes">&#x003ba;</italic>B pathway, provides new insights into potential therapeutic strategies.</p><p>Overall, the SARS-CoV-2 NP represents a promising focal point for future research and therapeutic development. The ongoing efforts in this field are a testament to the resilience and dedication of the scientific community. By focusing on the NP, researchers and healthcare professionals can develop more effective diagnostic tools, vaccines, and therapeutic strategies. This will not only enhance our ability to manage and treat COVID-19 but also address the persistent challenges posed by long COVID. The advancements in understanding and targeting the NP hold the promise of significantly improving patient outcomes and public health worldwide. The scientific community&#x02019;s commitment to unraveling the complexities of the NP will undoubtedly lead to breakthroughs that will benefit millions of people affected by COVID-19.</p></sec><sec><title>Summary and Future Directions</title><p>This review has delved into the pivotal role of the SARS-CoV-2 NP in the pathogenesis of COVID-19, emphasizing its involvement in hyperinflammation and thrombosis, which are critical factors in the disease&#x02019;s severity and long-term effects. The NP&#x02019;s interactions with host cell components, such as Toll-like receptor 2 (TLR2) and various signaling pathways, including NF-<italic toggle="yes">&#x003ba;</italic>B and MAPK, underscore its significant impact on endothelial dysfunction and immune response modulation. Key takeaways from this review include the NP&#x02019;s essential functions in viral replication and assembly, its ability to trigger hyperinflammation through interactions with host proteins, and its role in promoting thrombosis and endothelial dysfunction, which contribute to COVID-19-associated coagulopathy and long COVID symptoms. Understanding these mechanisms opens avenues for developing targeted therapies to mitigate both acute and chronic effects of COVID-19.</p><p>Despite significant advancements in understanding the SARS-CoV-2 NP, several knowledge gaps remain that warrant further investigation. Addressing these gaps is crucial for developing effective therapeutic strategies and improving our overall understanding of COVID-19 and its long-term effects. While it is known that the NP can modulate immune responses, the precise mechanisms by which it interacts with host immune pathways, such as NF-<italic toggle="yes">&#x003ba;</italic>B and MAPK, are not fully understood. Detailed studies are needed to elucidate how the NP influences these signaling pathways and the subsequent effects on immune cell activation and cytokine production. The exact role of the NP in the development and persistence of long COVID symptoms remains unclear. Longitudinal studies focusing on patients with long COVID are essential to determine the NP&#x02019;s contribution to persistent symptoms. Investigating the protein&#x02019;s interactions with host cells over time could provide insights into chronic inflammation and immune dysregulation associated with long COVID.</p><p>Mutations in the NP, particularly those affecting phosphorylation sites, have been linked to changes in viral replication and assembly. However, the broader implications of these mutations on viral fitness, immune evasion, and disease severity are not fully understood. Comparative studies of different SARS-CoV-2 variants with specific NP mutations can help clarify how these changes affect the virus&#x02019;s behavior and interaction with the host immune system. Although the NP is a promising target for antiviral therapies, there is limited information on the efficacy and safety of potential inhibitors. High-throughput screening of small molecules and peptides that can inhibit NP functions should be prioritized. Structural studies using techniques like cryo-electron microscopy can aid in the rational design of inhibitors. Additionally, preclinical and clinical trials are necessary to evaluate the therapeutic potential of these inhibitors.</p><p>The interplay between the NP and the host immune response is complex, and its implications for therapeutic development are not fully explored. Investigating the immune response to the NP, including the generation of neutralizing antibodies and T-cell responses, can inform vaccine design and immunotherapies. Studies should focus on how to enhance protective immunity while minimizing potential adverse effects, such as immune enhancement or autoimmunity.</p><p>In conclusion, the SARS-CoV-2 NP represents a promising focal point for future research and therapeutic development. The ongoing efforts in this field are a testament to the resilience and dedication of the scientific community. By focusing on the NP, researchers and healthcare professionals can develop more effective diagnostic tools, vaccines, and therapeutic strategies. This will not only enhance our ability to manage and treat COVID-19 but also address the persistent challenges posed by long COVID. The advancements in understanding and targeting the NP hold the promise of significantly improving patient outcomes and public health worldwide. The scientific community&#x02019;s commitment to unraveling the complexities of the NP will undoubtedly lead to breakthroughs that will benefit millions of people affected by COVID-19.</p></sec></body><back><sec sec-type="additional-information"><title>Additional Information and Declarations</title><fn-group content-type="competing-interests"><title>Competing Interests</title><fn id="conflict-1" fn-type="COI-statement"><p>Altijana Hromi&#x00107;-Jahjefendi&#x00107; is an Academic Editor for PeerJ. Vladimir N. Uversky is an Academic Editor and Section Editor for PeerJ. The other authors declare that they have no competing interests.</p></fn></fn-group><fn-group content-type="author-contributions"><title>Author Contributions</title><fn id="contribution-1" fn-type="con"><p><xref rid="author-1" ref-type="contrib">Ahmed Eltayeb</xref> conceived and designed the experiments, performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-2" fn-type="con"><p><xref rid="author-2" ref-type="contrib">Muhamed Adilovi&#x00107;</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-3" fn-type="con"><p><xref rid="author-3" ref-type="contrib">Maryam Golzardi</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-4" fn-type="con"><p><xref rid="author-4" ref-type="contrib">Altijana Hromi&#x00107;-Jahjefendi&#x00107;</xref> conceived and designed the experiments, performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-5" fn-type="con"><p><xref rid="author-5" ref-type="contrib">Alberto Rubio-Casillas</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-6" fn-type="con"><p><xref rid="author-6" ref-type="contrib">Vladimir N. Uversky</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p></fn><fn id="contribution-7" fn-type="con"><p><xref rid="author-7" ref-type="contrib">Elrashdy M. Redwan</xref> conceived and designed the experiments, performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p></fn></fn-group><fn-group content-type="other"><title>Data Availability</title><fn id="addinfo-1"><p>The following information was supplied regarding data availability:</p><p>This is a literature review.</p></fn></fn-group></sec><ref-list content-type="authoryear"><title>References</title><ref id="ref-1"><label>Abou-Ismail et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abou-Ismail</surname><given-names>MY</given-names></name>
<name><surname>Diamond</surname><given-names>A</given-names></name>
<name><surname>Kapoor</surname><given-names>S</given-names></name>
<name><surname>Arafah</surname><given-names>Y</given-names></name>
<name><surname>Nayak</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>The hypercoagulable state in COVID-19: incidence, pathophysiology, and management</article-title><source>Thrombosis Research</source><volume>194</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2020.06.029</pub-id><pub-id pub-id-type="pmid">32788101</pub-id>
</element-citation></ref><ref id="ref-2"><label>Almaz&#x000e1;n, Gal&#x000e1;n &#x00026; Enjuanes (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almaz&#x000e1;n</surname><given-names>F</given-names></name>
<name><surname>Gal&#x000e1;n</surname><given-names>C</given-names></name>
<name><surname>Enjuanes</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>The nucleoprotein is required for efficient coronavirus genome replication</article-title><source>Journal of Virology</source><volume>78</volume><fpage>12683</fpage><lpage>12688</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.22.12683-12688.2004</pub-id><pub-id pub-id-type="pmid">15507657</pub-id>
</element-citation></ref><ref id="ref-3"><label>Augustin et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Augustin</surname><given-names>M</given-names></name>
<name><surname>Schommers</surname><given-names>P</given-names></name>
<name><surname>Stecher</surname><given-names>M</given-names></name>
<name><surname>Dewald</surname><given-names>F</given-names></name>
<name><surname>Gieselmann</surname><given-names>L</given-names></name>
<name><surname>Gruell</surname><given-names>H</given-names></name>
<name><surname>Horn</surname><given-names>C</given-names></name>
<name><surname>Vanshylla</surname><given-names>K</given-names></name>
<name><surname>Cristanziano</surname><given-names>VD</given-names></name>
<name><surname>Osebold</surname><given-names>L</given-names></name>
<name><surname>Roventa</surname><given-names>M</given-names></name>
<name><surname>Riaz</surname><given-names>T</given-names></name>
<name><surname>Tschernoster</surname><given-names>N</given-names></name>
<name><surname>Altmueller</surname><given-names>J</given-names></name>
<name><surname>Rose</surname><given-names>L</given-names></name>
<name><surname>Salomon</surname><given-names>S</given-names></name>
<name><surname>Priesner</surname><given-names>V</given-names></name>
<name><surname>Luers</surname><given-names>JC</given-names></name>
<name><surname>Albus</surname><given-names>C</given-names></name>
<name><surname>Rosenkranz</surname><given-names>S</given-names></name>
<name><surname>Gathof</surname><given-names>B</given-names></name>
<name><surname>F&#x000e4;tkenheuer</surname><given-names>G</given-names></name>
<name><surname>Hallek</surname><given-names>M</given-names></name>
<name><surname>Klein</surname><given-names>F</given-names></name>
<name><surname>Su&#x000e1;rez</surname><given-names>I</given-names></name>
<name><surname>Lehmann</surname><given-names>C</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study</article-title><source>The Lancet Regional Health&#x02014;Europe</source><volume>6</volume><elocation-id>100122</elocation-id><pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100122</pub-id><pub-id pub-id-type="pmid">34027514</pub-id>
</element-citation></ref><ref id="ref-4"><label>Bai et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>Z</given-names></name>
<name><surname>Cao</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation</article-title><source>Viruses</source><volume>13</volume><fpage>1115</fpage><pub-id pub-id-type="doi">10.3390/v13061115</pub-id><pub-id pub-id-type="pmid">34200602</pub-id>
</element-citation></ref><ref id="ref-5"><label>Ballering et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ballering</surname><given-names>AV</given-names></name>
<name><surname>Van Zon</surname><given-names>SKR</given-names></name>
<name><surname>Olde Hartman</surname><given-names>TC</given-names></name>
<name><surname>Rosmalen</surname><given-names>JGM</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study</article-title><source>The Lancet</source><volume>400</volume><fpage>452</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(22)01214-4</pub-id></element-citation></ref><ref id="ref-6"><label>Ballouz et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ballouz</surname><given-names>T</given-names></name>
<name><surname>Menges</surname><given-names>D</given-names></name>
<name><surname>Anagnostopoulos</surname><given-names>A</given-names></name>
<name><surname>Domenghino</surname><given-names>A</given-names></name>
<name><surname>Aschmann</surname><given-names>HE</given-names></name>
<name><surname>Frei</surname><given-names>A</given-names></name>
<name><surname>Fehr</surname><given-names>JS</given-names></name>
<name><surname>Puhan</surname><given-names>MA</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study</article-title><source>BMJ</source><volume>381</volume><elocation-id>e074425</elocation-id><pub-id pub-id-type="doi">10.1136/bmj-2022-074425</pub-id><pub-id pub-id-type="pmid">37257891</pub-id>
</element-citation></ref><ref id="ref-7"><label>Baric et al. (1988)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baric</surname><given-names>RS</given-names></name>
<name><surname>Nelson</surname><given-names>GW</given-names></name>
<name><surname>Fleming</surname><given-names>JO</given-names></name>
<name><surname>Deans</surname><given-names>RJ</given-names></name>
<name><surname>Keck</surname><given-names>JG</given-names></name>
<name><surname>Casteel</surname><given-names>N</given-names></name>
<name><surname>Stohlman</surname><given-names>SA</given-names></name>
</person-group><year iso-8601-date="1988">1988</year><article-title>Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription</article-title><source>Journal of Virology</source><volume>62</volume><fpage>4280</fpage><lpage>4287</lpage><pub-id pub-id-type="doi">10.1128/jvi.62.11.4280-4287.1988</pub-id><pub-id pub-id-type="pmid">2845140</pub-id>
</element-citation></ref><ref id="ref-8"><label>Berentschot et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berentschot</surname><given-names>JC</given-names></name>
<name><surname>Bek</surname><given-names>LM</given-names></name>
<name><surname>Heijenbrok-Kal</surname><given-names>MH</given-names></name>
<name><surname>Van Bommel</surname><given-names>J</given-names></name>
<name><surname>Ribbers</surname><given-names>GM</given-names></name>
<name><surname>Aerts</surname><given-names>J</given-names></name>
<name><surname>Hellemons</surname><given-names>ME</given-names></name>
<name><surname>Van Den Berg-Emons</surname><given-names>HJG</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Long-term health outcomes of COVID-19 in ICU- and non-ICU-treated patients up to 2 years after hospitalization: a longitudinal cohort study (CO-FLOW)</article-title><source>Journal of Intensive Care</source><volume>12</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.1186/s40560-024-00748-w</pub-id><pub-id pub-id-type="pmid">39516956</pub-id>
</element-citation></ref><ref id="ref-9"><label>Bouhaddou et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouhaddou</surname><given-names>M</given-names></name>
<name><surname>Memon</surname><given-names>D</given-names></name>
<name><surname>Meyer</surname><given-names>B</given-names></name>
<name><surname>White</surname><given-names>KM</given-names></name>
<name><surname>Rezelj</surname><given-names>VV</given-names></name>
<name><surname>Correa Marrero</surname><given-names>M</given-names></name>
<name><surname>Polacco</surname><given-names>BJ</given-names></name>
<name><surname>Melnyk</surname><given-names>JE</given-names></name>
<name><surname>Ulferts</surname><given-names>S</given-names></name>
<name><surname>Kaake</surname><given-names>RM</given-names></name>
<name><surname>Batra</surname><given-names>J</given-names></name>
<name><surname>Richards</surname><given-names>AL</given-names></name>
<name><surname>Stevenson</surname><given-names>E</given-names></name>
<name><surname>Gordon</surname><given-names>DE</given-names></name>
<name><surname>Rojc</surname><given-names>A</given-names></name>
<name><surname>Obernier</surname><given-names>K</given-names></name>
<name><surname>Fabius</surname><given-names>JM</given-names></name>
<name><surname>Soucheray</surname><given-names>M</given-names></name>
<name><surname>Miorin</surname><given-names>L</given-names></name>
<name><surname>Moreno</surname><given-names>E</given-names></name>
<name><surname>Koh</surname><given-names>C</given-names></name>
<name><surname>Tran</surname><given-names>QD</given-names></name>
<name><surname>Hardy</surname><given-names>A</given-names></name>
<name><surname>Robinot</surname><given-names>R</given-names></name>
<name><surname>Vallet</surname><given-names>T</given-names></name>
<name><surname>Nilsson-Payant</surname><given-names>BE</given-names></name>
<name><surname>Hernandez-Armenta</surname><given-names>C</given-names></name>
<name><surname>Dunham</surname><given-names>A</given-names></name>
<name><surname>Weigang</surname><given-names>S</given-names></name>
<name><surname>Knerr</surname><given-names>J</given-names></name>
<name><surname>Modak</surname><given-names>M</given-names></name>
<name><surname>Quintero</surname><given-names>D</given-names></name>
<name><surname>Zhou</surname><given-names>Y</given-names></name>
<name><surname>Dugourd</surname><given-names>A</given-names></name>
<name><surname>Valdeolivas</surname><given-names>A</given-names></name>
<name><surname>Patil</surname><given-names>T</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<name><surname>H&#x000fc;ttenhain</surname><given-names>R</given-names></name>
<name><surname>Cakir</surname><given-names>M</given-names></name>
<name><surname>Muralidharan</surname><given-names>M</given-names></name>
<name><surname>Kim</surname><given-names>M</given-names></name>
<name><surname>Jang</surname><given-names>G</given-names></name>
<name><surname>Tutuncuoglu</surname><given-names>B</given-names></name>
<name><surname>Hiatt</surname><given-names>J</given-names></name>
<name><surname>Guo</surname><given-names>JZ</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Bouhaddou</surname><given-names>S</given-names></name>
<name><surname>Mathy</surname><given-names>CJP</given-names></name>
<name><surname>Gaulton</surname><given-names>A</given-names></name>
<name><surname>Manners</surname><given-names>EJ</given-names></name>
<name><surname>F&#x000e9;lix</surname><given-names>E</given-names></name>
<name><surname>Shi</surname><given-names>Y</given-names></name>
<name><surname>Goff</surname><given-names>M</given-names></name>
<name><surname>Lim</surname><given-names>JK</given-names></name>
<name><surname>McBride</surname><given-names>T</given-names></name>
<name><surname>O&#x02019;Neal</surname><given-names>MC</given-names></name>
<name><surname>Cai</surname><given-names>Y</given-names></name>
<name><surname>Chang</surname><given-names>JCJ</given-names></name>
<name><surname>Broadhurst</surname><given-names>DJ</given-names></name>
<name><surname>Klippsten</surname><given-names>S</given-names></name>
<name><surname>De Wit</surname><given-names>E</given-names></name>
<name><surname>Leach</surname><given-names>AR</given-names></name>
<name><surname>Kortemme</surname><given-names>T</given-names></name>
<name><surname>Shoichet</surname><given-names>B</given-names></name>
<name><surname>Ott</surname><given-names>M</given-names></name>
<name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name>
<name><surname>Ten Oever</surname><given-names>BR</given-names></name>
<name><surname>Mullins</surname><given-names>RD</given-names></name>
<name><surname>Fischer</surname><given-names>ER</given-names></name>
<name><surname>Kochs</surname><given-names>G</given-names></name>
<name><surname>Grosse</surname><given-names>R</given-names></name>
<name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A</given-names></name>
<name><surname>Vignuzzi</surname><given-names>M</given-names></name>
<name><surname>Johnson</surname><given-names>JR</given-names></name>
<name><surname>Shokat</surname><given-names>KM</given-names></name>
<name><surname>Swaney</surname><given-names>DL</given-names></name>
<name><surname>Beltrao</surname><given-names>P</given-names></name>
<name><surname>Krogan</surname><given-names>NJ</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>The global phosphorylation landscape of SARS-CoV-2 infection</article-title><source>Cell</source><volume>182</volume><fpage>685</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.034</pub-id><pub-id pub-id-type="pmid">32645325</pub-id>
</element-citation></ref><ref id="ref-10"><label>Brayton et al. (1982)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brayton</surname><given-names>PR</given-names></name>
<name><surname>Lai</surname><given-names>MM</given-names></name>
<name><surname>Patton</surname><given-names>CD</given-names></name>
<name><surname>Stohlman</surname><given-names>SA</given-names></name>
</person-group><year iso-8601-date="1982">1982</year><article-title>Characterization of two RNA polymerase activities induced by mouse hepatitis virus</article-title><source>Journal of Virology</source><volume>42</volume><fpage>847</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1128/jvi.42.3.847-853.1982</pub-id><pub-id pub-id-type="pmid">6285000</pub-id>
</element-citation></ref><ref id="ref-11"><label>Brodin (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brodin</surname><given-names>P</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Immune determinants of COVID-19 disease presentation and severity</article-title><source>Nature Medicine</source><volume>27</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-01202-8</pub-id></element-citation></ref><ref id="ref-12"><label>Cai et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cai</surname><given-names>T</given-names></name>
<name><surname>Yu</surname><given-names>Z</given-names></name>
<name><surname>Wang</surname><given-names>Z</given-names></name>
<name><surname>Liang</surname><given-names>C</given-names></name>
<name><surname>Richard</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Arginine methylation of SARS-CoV-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication</article-title><source>The Journal of Biological Chemistry</source><volume>297</volume><elocation-id>100821</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100821</pub-id><pub-id pub-id-type="pmid">34029587</pub-id>
</element-citation></ref><ref id="ref-13"><label>Carlson et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carlson</surname><given-names>CR</given-names></name>
<name><surname>Adly</surname><given-names>AN</given-names></name>
<name><surname>Bi</surname><given-names>M</given-names></name>
<name><surname>Howard</surname><given-names>CJ</given-names></name>
<name><surname>Frost</surname><given-names>A</given-names></name>
<name><surname>Cheng</surname><given-names>Y</given-names></name>
<name><surname>Morgan</surname><given-names>DO</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation</article-title><source>Journal of Biological Chemistry</source><volume>298</volume><elocation-id>102560</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102560</pub-id><pub-id pub-id-type="pmid">36202211</pub-id>
</element-citation></ref><ref id="ref-14"><label>Casais et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Casais</surname><given-names>R</given-names></name>
<name><surname>Thiel</surname><given-names>V</given-names></name>
<name><surname>Siddell</surname><given-names>SG</given-names></name>
<name><surname>Cavanagh</surname><given-names>D</given-names></name>
<name><surname>Britton</surname><given-names>P</given-names></name>
</person-group><year iso-8601-date="2001">2001</year><article-title>Reverse genetics system for the avian coronavirus infectious bronchitis virus</article-title><source>Journal of Virology</source><volume>75</volume><fpage>12359</fpage><lpage>12369</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.24.12359-12369.2001</pub-id><pub-id pub-id-type="pmid">11711626</pub-id>
</element-citation></ref><ref id="ref-15"><label>C&#x000e9;spedes et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>C&#x000e9;spedes</surname><given-names>PF</given-names></name>
<name><surname>Bueno</surname><given-names>SM</given-names></name>
<name><surname>Ram&#x000ed;rez</surname><given-names>BA</given-names></name>
<name><surname>Gomez</surname><given-names>RS</given-names></name>
<name><surname>Riquelme</surname><given-names>SA</given-names></name>
<name><surname>Palavecino</surname><given-names>CE</given-names></name>
<name><surname>Mackern-Oberti</surname><given-names>JP</given-names></name>
<name><surname>Mora</surname><given-names>JE</given-names></name>
<name><surname>Depoil</surname><given-names>D</given-names></name>
<name><surname>Sacrist&#x000e1;n</surname><given-names>C</given-names></name>
<name><surname>Cammer</surname><given-names>M</given-names></name>
<name><surname>Creneguy</surname><given-names>A</given-names></name>
<name><surname>Nguyen</surname><given-names>TH</given-names></name>
<name><surname>Riedel</surname><given-names>CA</given-names></name>
<name><surname>Dustin</surname><given-names>ML</given-names></name>
<name><surname>Kalergis</surname><given-names>AM</given-names></name>
</person-group><year iso-8601-date="2014">2014</year><article-title>Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>111</volume><fpage>E3214</fpage><lpage>E3223</lpage><pub-id pub-id-type="doi">10.1073/pnas.1400760111</pub-id><pub-id pub-id-type="pmid">25056968</pub-id>
</element-citation></ref><ref id="ref-16"><label>Chang et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>C-Y</given-names></name>
<name><surname>Liu</surname><given-names>HM</given-names></name>
<name><surname>Chang</surname><given-names>M-F</given-names></name>
<name><surname>Chang</surname><given-names>SC</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Middle east respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling</article-title><source>Journal of Virology</source><volume>94</volume><elocation-id>e00099-20</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00099-20</pub-id><pub-id pub-id-type="pmid">32295922</pub-id>
</element-citation></ref><ref id="ref-17"><label>Chen &#x00026; Makino (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C-J</given-names></name>
<name><surname>Makino</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Murine coronavirus replication induces cell cycle arrest in G<sub>0</sub>/G<sub>1</sub> phase</article-title><source>Journal of Virology</source><volume>78</volume><fpage>5658</fpage><lpage>5669</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.11.5658-5669.2004</pub-id><pub-id pub-id-type="pmid">15140963</pub-id>
</element-citation></ref><ref id="ref-18"><label>Chen et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C-J</given-names></name>
<name><surname>Sugiyama</surname><given-names>K</given-names></name>
<name><surname>Kubo</surname><given-names>H</given-names></name>
<name><surname>Huang</surname><given-names>C</given-names></name>
<name><surname>Makino</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Murine coronavirus nonstructural protein p28 arrests cell cycle in G<sub>0</sub>/G<sub>1</sub> phase</article-title><source>Journal of Virology</source><volume>78</volume><fpage>10410</fpage><lpage>10419</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.19.10410-10419.2004</pub-id><pub-id pub-id-type="pmid">15367607</pub-id>
</element-citation></ref><ref id="ref-19"><label>Chen et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H</given-names></name>
<name><surname>Gill</surname><given-names>A</given-names></name>
<name><surname>Dove</surname><given-names>BK</given-names></name>
<name><surname>Emmett</surname><given-names>SR</given-names></name>
<name><surname>Kemp</surname><given-names>CF</given-names></name>
<name><surname>Ritchie</surname><given-names>MA</given-names></name>
<name><surname>Dee</surname><given-names>M</given-names></name>
<name><surname>Hiscox</surname><given-names>JA</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA Binding by using surface plasmon resonance</article-title><source>Journal of Virology</source><volume>79</volume><fpage>1164</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.2.1164-1179.2005</pub-id><pub-id pub-id-type="pmid">15613344</pub-id>
</element-citation></ref><ref id="ref-20"><label>Chen et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Guan</surname><given-names>W-J</given-names></name>
<name><surname>Qiu</surname><given-names>Z-E</given-names></name>
<name><surname>Xu</surname><given-names>J-B</given-names></name>
<name><surname>Bai</surname><given-names>X</given-names></name>
<name><surname>Hou</surname><given-names>X-C</given-names></name>
<name><surname>Sun</surname><given-names>J</given-names></name>
<name><surname>Qu</surname><given-names>S</given-names></name>
<name><surname>Huang</surname><given-names>Z-X</given-names></name>
<name><surname>Lei</surname><given-names>T-L</given-names></name>
<name><surname>Huang</surname><given-names>Z-Y</given-names></name>
<name><surname>Zhao</surname><given-names>J</given-names></name>
<name><surname>Zhu</surname><given-names>Y-X</given-names></name>
<name><surname>Ye</surname><given-names>K-N</given-names></name>
<name><surname>Lun</surname><given-names>Z-R</given-names></name>
<name><surname>Zhou</surname><given-names>W-L</given-names></name>
<name><surname>Zhong</surname><given-names>N-S</given-names></name>
<name><surname>Zhang</surname><given-names>Y-L</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>SARS-CoV-2 nucleocapsid protein triggers hyperinflammation <italic toggle="yes">via</italic> protein-protein interaction-mediated intracellular Cl&#x02014;accumulation in respiratory epithelium</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><fpage>255</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01048-1</pub-id><pub-id pub-id-type="pmid">35896532</pub-id>
</element-citation></ref><ref id="ref-21"><label>Cheng et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>N</given-names></name>
<name><surname>Liu</surname><given-names>M</given-names></name>
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>Sun</surname><given-names>B</given-names></name>
<name><surname>Liu</surname><given-names>D</given-names></name>
<name><surname>Wang</surname><given-names>G</given-names></name>
<name><surname>Shi</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>Protein post-translational modification in SARS-CoV-2 and host interaction</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>1068449</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.1068449</pub-id><pub-id pub-id-type="pmid">36713387</pub-id>
</element-citation></ref><ref id="ref-22"><label>Cologna &#x00026; Hogue (1998)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cologna</surname><given-names>R</given-names></name>
<name><surname>Hogue</surname><given-names>BG</given-names></name>
</person-group><year iso-8601-date="1998">1998</year><article-title>Coronavirus nucleocapsid protein, RNA interactions</article-title><source>Advances in Experimental Medicine and Biology</source><volume>440</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1007/978-1-4615-5331-1_46</pub-id><pub-id pub-id-type="pmid">9782303</pub-id>
</element-citation></ref><ref id="ref-23"><label>Cong et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cong</surname><given-names>Y</given-names></name>
<name><surname>Ulasli</surname><given-names>M</given-names></name>
<name><surname>Schepers</surname><given-names>H</given-names></name>
<name><surname>Mauthe</surname><given-names>M</given-names></name>
<name><surname>V&#x02019;kovski</surname><given-names>P</given-names></name>
<name><surname>Kriegenburg</surname><given-names>F</given-names></name>
<name><surname>Thiel</surname><given-names>V</given-names></name>
<name><surname>De Haan</surname><given-names>CAM</given-names></name>
<name><surname>Reggiori</surname><given-names>F</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle</article-title><source>Journal of Virology</source><volume>94</volume><elocation-id>e01925-19</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01925-19</pub-id><pub-id pub-id-type="pmid">31776274</pub-id>
</element-citation></ref><ref id="ref-24"><label>Cristofari &#x00026; Darlix (2002)</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Cristofari</surname><given-names>G</given-names></name>
<name><surname>Darlix</surname><given-names>J-L</given-names></name>
</person-group><year iso-8601-date="2002">2002</year><article-title>The ubiquitous nature of RNA chaperone proteins</article-title><source>Progress in nucleic acid research and molecular biology</source><publisher-name>Academic press</publisher-name><publisher-loc>Cambridge, MA</publisher-loc><volume>vol. 72</volume><fpage>223</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/S0079-6603(02)72071-0</pub-id><pub-id pub-id-type="pmid">12206453</pub-id>
</element-citation></ref><ref id="ref-25"><label>D&#x02019;Alessio (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>D&#x02019;Alessio</surname><given-names>A</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>Role of endothelial cell metabolism in normal and tumor vasculature</article-title><source>Cancers</source><volume>15</volume><fpage>1921</fpage><pub-id pub-id-type="doi">10.3390/cancers15071921</pub-id><pub-id pub-id-type="pmid">37046582</pub-id>
</element-citation></ref><ref id="ref-26"><label>Davies, Dourmashkin &#x00026; Macnaughton (1981)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davies</surname><given-names>HA</given-names></name>
<name><surname>Dourmashkin</surname><given-names>RR</given-names></name>
<name><surname>Macnaughton</surname><given-names>MR</given-names></name>
</person-group><year iso-8601-date="1981">1981</year><article-title>Ribonucleoprotein of avian infectious bronchitis virus</article-title><source>Journal of General Virology</source><volume>53</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-53-1-67</pub-id><pub-id pub-id-type="pmid">6268741</pub-id>
</element-citation></ref><ref id="ref-27"><label>Dayhoff &#x00026; Uversky (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dayhoff</surname><given-names>GW</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Rapid prediction and analysis of protein intrinsic disorder</article-title><source>Protein Science: A Publication of the Protein Society</source><volume>31</volume><elocation-id>e4496</elocation-id><pub-id pub-id-type="doi">10.1002/pro.4496</pub-id><pub-id pub-id-type="pmid">36334049</pub-id>
</element-citation></ref><ref id="ref-28"><label>De Haan et al. (1998)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Haan</surname><given-names>CAM</given-names></name>
<name><surname>Kuo</surname><given-names>L</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
<name><surname>Vennema</surname><given-names>H</given-names></name>
<name><surname>Rottier</surname><given-names>PJM</given-names></name>
</person-group><year iso-8601-date="1998">1998</year><article-title>Coronavirus particle assembly: primary structure requirements of the membrane protein</article-title><source>Journal of Virology</source><volume>72</volume><fpage>6838</fpage><lpage>6850</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.8.6838-6850.1998</pub-id><pub-id pub-id-type="pmid">9658133</pub-id>
</element-citation></ref><ref id="ref-29"><label>De Haan &#x00026; Rottier (2005)</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>De Haan</surname><given-names>CAM</given-names></name>
<name><surname>Rottier</surname><given-names>PJM</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>Molecular interactions in the assembly of coronaviruses</article-title><source>Advances in virus research</source><publisher-loc>Amsterdam, Netherlands</publisher-loc><publisher-name>Elsevier</publisher-name><volume>vol. 65</volume><fpage>165</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/S0065-3527(05)64006-7</pub-id></element-citation></ref><ref id="ref-30"><label>De Haan et al. (1999)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Haan</surname><given-names>CAM</given-names></name>
<name><surname>Smeets</surname><given-names>M</given-names></name>
<name><surname>Vernooij</surname><given-names>F</given-names></name>
<name><surname>Vennema</surname><given-names>H</given-names></name>
<name><surname>Rottier</surname><given-names>PJM</given-names></name>
</person-group><year iso-8601-date="1999">1999</year><article-title>Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein</article-title><source>Journal of Virology</source><volume>73</volume><fpage>7441</fpage><lpage>7452</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.9.7441-7452.1999</pub-id><pub-id pub-id-type="pmid">10438834</pub-id>
</element-citation></ref><ref id="ref-31"><label>Denison et al. (1999)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denison</surname><given-names>MR</given-names></name>
<name><surname>Spaan</surname><given-names>WJM</given-names></name>
<name><surname>Van Der Meer</surname><given-names>Y</given-names></name>
<name><surname>Gibson</surname><given-names>CA</given-names></name>
<name><surname>Sims</surname><given-names>AC</given-names></name>
<name><surname>Prentice</surname><given-names>E</given-names></name>
<name><surname>Lu</surname><given-names>XT</given-names></name>
</person-group><year iso-8601-date="1999">1999</year><article-title>The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis</article-title><source>Journal of Virology</source><volume>73</volume><fpage>6862</fpage><lpage>6871</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.8.6862-6871.1999</pub-id><pub-id pub-id-type="pmid">10400784</pub-id>
</element-citation></ref><ref id="ref-32"><label>Deppert &#x00026; Henning (1980)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deppert</surname><given-names>W</given-names></name>
<name><surname>Henning</surname><given-names>R</given-names></name>
</person-group><year iso-8601-date="1980">1980</year><article-title>SV40 T-antigen-related molecules on the surfaces of hela cells infected with adenovirus-2-SV40 hybrids and on SV40-transformed cells</article-title><source>Cold Spring Harbor Symposia on Quantitative Biology</source><volume>44</volume><fpage>225</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1101/SQB.1980.044.01.026</pub-id><pub-id pub-id-type="pmid">6253136</pub-id>
</element-citation></ref><ref id="ref-33"><label>Di et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di</surname><given-names>D</given-names></name>
<name><surname>Dileepan</surname><given-names>M</given-names></name>
<name><surname>Ahmed</surname><given-names>S</given-names></name>
<name><surname>Liang</surname><given-names>Y</given-names></name>
<name><surname>Ly</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Recombinant SARS-CoV-2 nucleocapsid protein: expression, purification, and its biochemical characterization and utility in serological assay development to assess immunological responses to SARS-CoV-2 infection</article-title><source>Pathogens</source><volume>10</volume><fpage>1039</fpage><pub-id pub-id-type="doi">10.3390/pathogens10081039</pub-id><pub-id pub-id-type="pmid">34451501</pub-id>
</element-citation></ref><ref id="ref-34"><label>Di Salvo et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Salvo</surname><given-names>E</given-names></name>
<name><surname>Di Gioacchino</surname><given-names>M</given-names></name>
<name><surname>Tonacci</surname><given-names>A</given-names></name>
<name><surname>Casciaro</surname><given-names>M</given-names></name>
<name><surname>Gangemi</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Alarmins, COVID-19 and comorbidities</article-title><source>Annals of Medicine</source><volume>53</volume><fpage>777</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1080/07853890.2021.1921252</pub-id><pub-id pub-id-type="pmid">34042528</pub-id>
</element-citation></ref><ref id="ref-35"><label>Djukic et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Djukic</surname><given-names>T</given-names></name>
<name><surname>Mladenovic</surname><given-names>M</given-names></name>
<name><surname>Stanic-Vucinic</surname><given-names>D</given-names></name>
<name><surname>Radosavljevic</surname><given-names>J</given-names></name>
<name><surname>Smiljanic</surname><given-names>K</given-names></name>
<name><surname>Sabljic</surname><given-names>L</given-names></name>
<name><surname>Devic</surname><given-names>M</given-names></name>
<name><surname>Cujic</surname><given-names>D</given-names></name>
<name><surname>Vasovic</surname><given-names>T</given-names></name>
<name><surname>Simovic</surname><given-names>A</given-names></name>
<name><surname>Radomirovic</surname><given-names>M</given-names></name>
<name><surname>Cirkovic Velickovic</surname><given-names>T</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2</article-title><source>Virology</source><volume>557</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2021.01.004</pub-id><pub-id pub-id-type="pmid">33582454</pub-id>
</element-citation></ref><ref id="ref-36"><label>Edalat et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Edalat</surname><given-names>F</given-names></name>
<name><surname>Khakpour</surname><given-names>N</given-names></name>
<name><surname>Heli</surname><given-names>H</given-names></name>
<name><surname>Letafati</surname><given-names>A</given-names></name>
<name><surname>Ramezani</surname><given-names>A</given-names></name>
<name><surname>Hosseini</surname><given-names>SY</given-names></name>
<name><surname>Moattari</surname><given-names>A</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Immunological mechanisms of the nucleocapsid protein in COVID-19</article-title><source>Scientific Reports</source><volume>14</volume><fpage>3711</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-53906-3</pub-id><pub-id pub-id-type="pmid">38355695</pub-id>
</element-citation></ref><ref id="ref-37"><label>Eltayeb et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eltayeb</surname><given-names>A</given-names></name>
<name><surname>Al-Sarraj</surname><given-names>F</given-names></name>
<name><surname>Alharbi</surname><given-names>M</given-names></name>
<name><surname>Albiheyri</surname><given-names>R</given-names></name>
<name><surname>Mattar</surname><given-names>EH</given-names></name>
<name><surname>Abu Zeid</surname><given-names>IM</given-names></name>
<name><surname>Bouback</surname><given-names>TA</given-names></name>
<name><surname>Bamagoos</surname><given-names>A</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
<name><surname>Rubio-Casillas</surname><given-names>A</given-names></name>
<name><surname>Redwan</surname><given-names>EM</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS-CoV-2 nucleocapsid protein and its liquid-liquid phase separation</article-title><source>Journal of Cellular Biochemistry</source><volume>125</volume><elocation-id>e30530</elocation-id><pub-id pub-id-type="doi">10.1002/jcb.30530</pub-id><pub-id pub-id-type="pmid">38349116</pub-id>
</element-citation></ref><ref id="ref-38"><label>Escors et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Escors</surname><given-names>D</given-names></name>
<name><surname>Ortego</surname><given-names>J</given-names></name>
<name><surname>Laude</surname><given-names>H</given-names></name>
<name><surname>Enjuanes</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2001">2001</year><article-title>The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability</article-title><source>Journal of Virology</source><volume>75</volume><fpage>1312</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.3.1312-1324.2001</pub-id><pub-id pub-id-type="pmid">11152504</pub-id>
</element-citation></ref><ref id="ref-39"><label>Fan et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fan</surname><given-names>H</given-names></name>
<name><surname>Ooi</surname><given-names>A</given-names></name>
<name><surname>Tan</surname><given-names>YW</given-names></name>
<name><surname>Wang</surname><given-names>S</given-names></name>
<name><surname>Fang</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>DX</given-names></name>
<name><surname>Lescar</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its n-terminal domain and multimerization properties</article-title><source>Structure</source><volume>13</volume><fpage>1859</fpage><lpage>1868</lpage><pub-id pub-id-type="doi">10.1016/j.str.2005.08.021</pub-id><pub-id pub-id-type="pmid">16338414</pub-id>
</element-citation></ref><ref id="ref-40"><label>F&#x000e9;l&#x000e9;tou (2011)</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>F&#x000e9;l&#x000e9;tou</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2011">2011</year><article-title>Multiple functions of the endothelial cells</article-title><source>The endothelium: part 1: multiple functions of the endothelial cells&#x02014;focus on endothelium-derived vasoactive mediators</source><publisher-name>Morgan &#x00026; Claypool Life Sciences</publisher-name><publisher-loc>San Rafael, CA</publisher-loc></element-citation></ref><ref id="ref-41"><label>Foley &#x00026; Conway (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foley</surname><given-names>JH</given-names></name>
<name><surname>Conway</surname><given-names>EM</given-names></name>
</person-group><year iso-8601-date="2016">2016</year><article-title>Cross talk pathways between coagulation and inflammation</article-title><source>Circulation Research</source><volume>118</volume><fpage>1392</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.306853</pub-id><pub-id pub-id-type="pmid">27126649</pub-id>
</element-citation></ref><ref id="ref-42"><label>Foreman et al. (1994)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foreman</surname><given-names>KE</given-names></name>
<name><surname>Vaporciyan</surname><given-names>AA</given-names></name>
<name><surname>Bonish</surname><given-names>BK</given-names></name>
<name><surname>Jones</surname><given-names>ML</given-names></name>
<name><surname>Johnson</surname><given-names>KJ</given-names></name>
<name><surname>Glovsky</surname><given-names>MM</given-names></name>
<name><surname>Eddy</surname><given-names>SM</given-names></name>
<name><surname>Ward</surname><given-names>PA</given-names></name>
</person-group><year iso-8601-date="1994">1994</year><article-title>C5a-induced expression of P-selectin in endothelial cells</article-title><source>Journal of Clinical Investigation</source><volume>94</volume><fpage>1147</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1172/JCI117430</pub-id><pub-id pub-id-type="pmid">7521884</pub-id>
</element-citation></ref><ref id="ref-43"><label>Franco et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Franco</surname><given-names>JVA</given-names></name>
<name><surname>Garegnani</surname><given-names>LI</given-names></name>
<name><surname>Metzendorf</surname><given-names>MI</given-names></name>
<name><surname>Heldt</surname><given-names>K</given-names></name>
<name><surname>Mumm</surname><given-names>R</given-names></name>
<name><surname>Scheidt-Nave</surname><given-names>C</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies</article-title><source>BMJ Medicine</source><volume>3</volume><elocation-id>e000723</elocation-id><pub-id pub-id-type="doi">10.1136/bmjmed-2023-000723</pub-id><pub-id pub-id-type="pmid">38293681</pub-id>
</element-citation></ref><ref id="ref-44"><label>Fung &#x00026; Liu (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fung</surname><given-names>TS</given-names></name>
<name><surname>Liu</surname><given-names>DX</given-names></name>
</person-group><year iso-8601-date="2018">2018</year><article-title>Post-translational modifications of coronavirus proteins: roles and function</article-title><source>Future Virology</source><volume>13</volume><fpage>405</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.2217/fvl-2018-0008</pub-id><pub-id pub-id-type="pmid">32201497</pub-id>
</element-citation></ref><ref id="ref-45"><label>Fust&#x000e9; et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fust&#x000e9;</surname><given-names>B</given-names></name>
<name><surname>Mazzara</surname><given-names>R</given-names></name>
<name><surname>Escolar</surname><given-names>G</given-names></name>
<name><surname>Merino</surname><given-names>A</given-names></name>
<name><surname>Ordinas</surname><given-names>A</given-names></name>
<name><surname>D&#x000ed;az-Ricart</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK</article-title><source>Haematologica</source><volume>89</volume><fpage>578</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">15136221</pub-id>
</element-citation></ref><ref id="ref-46"><label>Gao et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>T</given-names></name>
<name><surname>Zhu</surname><given-names>L</given-names></name>
<name><surname>Liu</surname><given-names>H</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>T</given-names></name>
<name><surname>Fu</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Dong</surname><given-names>Q</given-names></name>
<name><surname>Hu</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>Z</given-names></name>
<name><surname>Jin</surname><given-names>J</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Yang</surname><given-names>W</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Jin</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>K</given-names></name>
<name><surname>Xiao</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Zhao</surname><given-names>H</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>P</given-names></name>
<name><surname>Song</surname><given-names>J</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Kang</surname><given-names>S</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Ma</surname><given-names>Q</given-names></name>
<name><surname>Bian</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>W</given-names></name>
<name><surname>Liu</surname><given-names>X</given-names></name>
<name><surname>Mao</surname><given-names>Q</given-names></name>
<name><surname>Cao</surname><given-names>C</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><fpage>318</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01133-5</pub-id><pub-id pub-id-type="pmid">36100602</pub-id>
</element-citation></ref><ref id="ref-47"><label>Garc&#x000ed;a-Abell&#x000e1;n et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ed;a-Abell&#x000e1;n</surname><given-names>J</given-names></name>
<name><surname>Padilla</surname><given-names>S</given-names></name>
<name><surname>Fern&#x000e1;ndez-Gonz&#x000e1;lez</surname><given-names>M</given-names></name>
<name><surname>Garc&#x000ed;a</surname><given-names>JA</given-names></name>
<name><surname>Agull&#x000f3;</surname><given-names>V</given-names></name>
<name><surname>Andreo</surname><given-names>M</given-names></name>
<name><surname>Ruiz</surname><given-names>S</given-names></name>
<name><surname>Galiana</surname><given-names>A</given-names></name>
<name><surname>Guti&#x000e9;rrez</surname><given-names>F</given-names></name>
<name><surname>Masi&#x000e1;</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study</article-title><source>Journal of Clinical Immunology</source><volume>41</volume><fpage>1490</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1007/s10875-021-01083-7</pub-id><pub-id pub-id-type="pmid">34273064</pub-id>
</element-citation></ref><ref id="ref-48"><label>Giannis, Ziogas &#x00026; Gianni (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giannis</surname><given-names>D</given-names></name>
<name><surname>Ziogas</surname><given-names>IA</given-names></name>
<name><surname>Gianni</surname><given-names>P</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past</article-title><source>Journal of Clinical Virology</source><volume>127</volume><elocation-id>104362</elocation-id><pub-id pub-id-type="doi">10.1016/j.jcv.2020.104362</pub-id><pub-id pub-id-type="pmid">32305883</pub-id>
</element-citation></ref><ref id="ref-49"><label>Golzardi et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Golzardi</surname><given-names>M</given-names></name>
<name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>A</given-names></name>
<name><surname>&#x00160;utkovi&#x00107;</surname><given-names>J</given-names></name>
<name><surname>Aydin</surname><given-names>O</given-names></name>
<name><surname>&#x000dc;nal-Ayd&#x00131;n</surname><given-names>P</given-names></name>
<name><surname>Be&#x00107;irevi&#x00107;</surname><given-names>T</given-names></name>
<name><surname>Redwan</surname><given-names>EM</given-names></name>
<name><surname>Rubio-Casillas</surname><given-names>A</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>The aftermath of COVID-19: exploring the long-term effects on organ systems</article-title><source>Biomedicines</source><volume>12</volume><fpage>913</fpage><pub-id pub-id-type="doi">10.3390/biomedicines12040913</pub-id><pub-id pub-id-type="pmid">38672267</pub-id>
</element-citation></ref><ref id="ref-50"><label>Gomez-Salinero &#x00026; Rafii (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomez-Salinero</surname><given-names>JM</given-names></name>
<name><surname>Rafii</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial cell adaptation in regeneration</article-title><source>Science</source><volume>362</volume><fpage>1116</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1126/science.aar4800</pub-id><pub-id pub-id-type="pmid">30523098</pub-id>
</element-citation></ref><ref id="ref-51"><label>Gorog et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gorog</surname><given-names>DA</given-names></name>
<name><surname>Storey</surname><given-names>RF</given-names></name>
<name><surname>Gurbel</surname><given-names>PA</given-names></name>
<name><surname>Tantry</surname><given-names>US</given-names></name>
<name><surname>Berger</surname><given-names>JS</given-names></name>
<name><surname>Chan</surname><given-names>MY</given-names></name>
<name><surname>Duerschmied</surname><given-names>D</given-names></name>
<name><surname>Smyth</surname><given-names>SS</given-names></name>
<name><surname>W. Parker</surname><given-names>AE</given-names></name>
<name><surname>Ajjan</surname><given-names>RA</given-names></name>
<name><surname>Vilahur</surname><given-names>G</given-names></name>
<name><surname>Badimon</surname><given-names>L</given-names></name>
<name><surname>Berg</surname><given-names>JMT</given-names></name>
<name><surname>Cate</surname><given-names>HT</given-names></name>
<name><surname>Peyvandi</surname><given-names>F</given-names></name>
<name><surname>Wang</surname><given-names>TT</given-names></name>
<name><surname>Becker</surname><given-names>RC</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium</article-title><source>Nature Reviews Cardiology</source><volume>19</volume><issue>7</issue><fpage>475</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/s41569-021-00665-7</pub-id><pub-id pub-id-type="pmid">35027697</pub-id>
</element-citation></ref><ref id="ref-52"><label>Goshua et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goshua</surname><given-names>G</given-names></name>
<name><surname>Pine</surname><given-names>AB</given-names></name>
<name><surname>Meizlish</surname><given-names>ML</given-names></name>
<name><surname>Chang</surname><given-names>C-H</given-names></name>
<name><surname>Zhang</surname><given-names>H</given-names></name>
<name><surname>Bahel</surname><given-names>P</given-names></name>
<name><surname>Baluha</surname><given-names>A</given-names></name>
<name><surname>Bar</surname><given-names>N</given-names></name>
<name><surname>Bona</surname><given-names>RD</given-names></name>
<name><surname>Burns</surname><given-names>AJ</given-names></name>
<name><surname>Dela Cruz</surname><given-names>CS</given-names></name>
<name><surname>Dumont</surname><given-names>A</given-names></name>
<name><surname>Halene</surname><given-names>S</given-names></name>
<name><surname>Hwa</surname><given-names>J</given-names></name>
<name><surname>Koff</surname><given-names>J</given-names></name>
<name><surname>Menninger</surname><given-names>H</given-names></name>
<name><surname>Neparidze</surname><given-names>N</given-names></name>
<name><surname>Price</surname><given-names>C</given-names></name>
<name><surname>Siner</surname><given-names>JM</given-names></name>
<name><surname>Tormey</surname><given-names>C</given-names></name>
<name><surname>Rinder</surname><given-names>HM</given-names></name>
<name><surname>Chun</surname><given-names>HJ</given-names></name>
<name><surname>Lee</surname><given-names>AI</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study</article-title><source>The Lancet Haematology</source><volume>7</volume><elocation-id>e575&#x02013;e582</elocation-id><pub-id pub-id-type="doi">10.1016/S2352-3026(20)30216-7</pub-id><pub-id pub-id-type="pmid">32619411</pub-id>
</element-citation></ref><ref id="ref-53"><label>Goswami et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goswami</surname><given-names>J</given-names></name>
<name><surname>MacArthur</surname><given-names>TA</given-names></name>
<name><surname>Sridharan</surname><given-names>M</given-names></name>
<name><surname>Pruthi</surname><given-names>RK</given-names></name>
<name><surname>McBane</surname><given-names>RD</given-names></name>
<name><surname>Witzig</surname><given-names>TE</given-names></name>
<name><surname>Park</surname><given-names>MS</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>A review of pathophysiology, clinical features, and management options of COVID-19 associated coagulopathy</article-title><source>Shock</source><volume>55</volume><fpage>700</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000001680</pub-id><pub-id pub-id-type="pmid">33378321</pub-id>
</element-citation></ref><ref id="ref-54"><label>Graham &#x00026; Denison (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Graham</surname><given-names>RL</given-names></name>
<name><surname>Denison</surname><given-names>MR</given-names></name>
</person-group><year iso-8601-date="2006">2006</year><article-title>Replication of murine hepatitis virus is regulated by papain-like proteinase 1 processing of nonstructural proteins 1 2, and 3</article-title><source>Journal of Virology</source><volume>80</volume><fpage>11610</fpage><lpage>11620</lpage><pub-id pub-id-type="doi">10.1128/JVI.01428-06</pub-id><pub-id pub-id-type="pmid">16971428</pub-id>
</element-citation></ref><ref id="ref-55"><label>Grunewald et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grunewald</surname><given-names>ME</given-names></name>
<name><surname>Fehr</surname><given-names>AR</given-names></name>
<name><surname>Athmer</surname><given-names>J</given-names></name>
<name><surname>Perlman</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2018">2018</year><article-title>The coronavirus nucleocapsid protein is ADP-ribosylated</article-title><source>Virology</source><volume>517</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2017.11.020</pub-id><pub-id pub-id-type="pmid">29199039</pub-id>
</element-citation></ref><ref id="ref-56"><label>He et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>R</given-names></name>
<name><surname>Dobie</surname><given-names>F</given-names></name>
<name><surname>Ballantine</surname><given-names>M</given-names></name>
<name><surname>Leeson</surname><given-names>A</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Bastien</surname><given-names>N</given-names></name>
<name><surname>Cutts</surname><given-names>T</given-names></name>
<name><surname>Andonov</surname><given-names>A</given-names></name>
<name><surname>Cao</surname><given-names>J</given-names></name>
<name><surname>Booth</surname><given-names>TF</given-names></name>
<name><surname>Plummer</surname><given-names>FA</given-names></name>
<name><surname>Tyler</surname><given-names>S</given-names></name>
<name><surname>Baker</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Analysis of multimerization of the SARS coronavirus nucleocapsid protein</article-title><source>Biochemical and Biophysical Research Communications</source><volume>316</volume><fpage>476</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.02.074</pub-id><pub-id pub-id-type="pmid">15020242</pub-id>
</element-citation></ref><ref id="ref-57"><label>Herschlag (1995)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Herschlag</surname><given-names>D</given-names></name>
</person-group><year iso-8601-date="1995">1995</year><article-title>RNA chaperones and the RNA folding problem</article-title><source>Journal of Biological Chemistry</source><volume>270</volume><fpage>20871</fpage><lpage>20874</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.36.20871</pub-id><pub-id pub-id-type="pmid">7545662</pub-id>
</element-citation></ref><ref id="ref-58"><label>Hromi&#x00107;-Jahjefendi&#x00107; et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>A</given-names></name>
<name><surname>Barh</surname><given-names>D</given-names></name>
<name><surname>Ramalho Pinto</surname><given-names>CH</given-names></name>
<name><surname>Gabriel Rodrigues Gomes</surname><given-names>L</given-names></name>
<name><surname>Pican&#x000e7;o Machado</surname><given-names>JL</given-names></name>
<name><surname>Afolabi</surname><given-names>OO</given-names></name>
<name><surname>Tiwari</surname><given-names>S</given-names></name>
<name><surname>Aljabali</surname><given-names>AAA</given-names></name>
<name><surname>Tambuwala</surname><given-names>MM</given-names></name>
<name><surname>Serrano-Aroca</surname><given-names>&#x000c1;</given-names></name>
<name><surname>Redwan</surname><given-names>EM</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
<name><surname>Lundstrom</surname><given-names>K</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Associations and disease&#x02013;disease interactions of COVID-19 with congenital and genetic disorders: a comprehensive review</article-title><source>Viruses</source><volume>14</volume><fpage>910</fpage><pub-id pub-id-type="doi">10.3390/v14050910</pub-id><pub-id pub-id-type="pmid">35632654</pub-id>
</element-citation></ref><ref id="ref-59"><label>Hromi&#x00107;-Jahjefendi&#x00107; et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>A</given-names></name>
<name><surname>Barh</surname><given-names>D</given-names></name>
<name><surname>Uversky</surname><given-names>V</given-names></name>
<name><surname>Aljabali</surname><given-names>AA</given-names></name>
<name><surname>Tambuwala</surname><given-names>MM</given-names></name>
<name><surname>Alzahrani</surname><given-names>KJ</given-names></name>
<name><surname>Alzahrani</surname><given-names>FM</given-names></name>
<name><surname>Alshammeri</surname><given-names>S</given-names></name>
<name><surname>Lundstrom</surname><given-names>K</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>Can COVID-19 vaccines induce premature non-communicable diseases: where are we heading to?</article-title><source>Vaccines</source><volume>11</volume><fpage>208</fpage><pub-id pub-id-type="doi">10.3390/vaccines11020208</pub-id><pub-id pub-id-type="pmid">36851087</pub-id>
</element-citation></ref><ref id="ref-60"><label>Hu et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>B</given-names></name>
<name><surname>Guo</surname><given-names>H</given-names></name>
<name><surname>Zhou</surname><given-names>P</given-names></name>
<name><surname>Shi</surname><given-names>Z-L</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Characteristics of SARS-CoV-2 and COVID-19</article-title><source>Nature Reviews Microbiology</source><volume>19</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-00459-7</pub-id><pub-id pub-id-type="pmid">33024307</pub-id>
</element-citation></ref><ref id="ref-61"><label>Huang et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Q</given-names></name>
<name><surname>Yu</surname><given-names>L</given-names></name>
<name><surname>Petros</surname><given-names>AM</given-names></name>
<name><surname>Gunasekera</surname><given-names>A</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Xu</surname><given-names>N</given-names></name>
<name><surname>Hajduk</surname><given-names>P</given-names></name>
<name><surname>Mack</surname><given-names>J</given-names></name>
<name><surname>Fesik</surname><given-names>SW</given-names></name>
<name><surname>Olejniczak</surname><given-names>ET</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein</article-title><source>Biochemistry</source><volume>43</volume><fpage>6059</fpage><lpage>6063</lpage><pub-id pub-id-type="doi">10.1021/bi036155b</pub-id><pub-id pub-id-type="pmid">15147189</pub-id>
</element-citation></ref><ref id="ref-62"><label>Hurst, Koetzner &#x00026; Masters (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hurst</surname><given-names>KR</given-names></name>
<name><surname>Koetzner</surname><given-names>CA</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2009">2009</year><article-title>Identification of <italic toggle="yes">in vivo</italic>-interacting domains of the murine coronavirus nucleocapsid protein</article-title><source>Journal of Virology</source><volume>83</volume><fpage>7221</fpage><lpage>7234</lpage><pub-id pub-id-type="doi">10.1128/JVI.00440-09</pub-id><pub-id pub-id-type="pmid">19420077</pub-id>
</element-citation></ref><ref id="ref-63"><label>Hurst, Koetzner &#x00026; Masters (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hurst</surname><given-names>KR</given-names></name>
<name><surname>Koetzner</surname><given-names>CA</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2013">2013</year><article-title>Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex</article-title><source>Journal of Virology</source><volume>87</volume><fpage>9159</fpage><lpage>9172</lpage><pub-id pub-id-type="doi">10.1128/JVI.01275-13</pub-id><pub-id pub-id-type="pmid">23760243</pub-id>
</element-citation></ref><ref id="ref-64"><label>Hurst et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hurst</surname><given-names>KR</given-names></name>
<name><surname>Ye</surname><given-names>R</given-names></name>
<name><surname>Goebel</surname><given-names>SJ</given-names></name>
<name><surname>Jayaraman</surname><given-names>P</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2010">2010</year><article-title>An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA</article-title><source>Journal of Virology</source><volume>84</volume><fpage>10276</fpage><lpage>10288</lpage><pub-id pub-id-type="doi">10.1128/JVI.01287-10</pub-id><pub-id pub-id-type="pmid">20660183</pub-id>
</element-citation></ref><ref id="ref-65"><label>Ikeda et al. (1998)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ikeda</surname><given-names>K</given-names></name>
<name><surname>Monden</surname><given-names>T</given-names></name>
<name><surname>Kanoh</surname><given-names>T</given-names></name>
<name><surname>Tsujie</surname><given-names>M</given-names></name>
<name><surname>Izawa</surname><given-names>H</given-names></name>
<name><surname>Haba</surname><given-names>A</given-names></name>
<name><surname>Ohnishi</surname><given-names>T</given-names></name>
<name><surname>Sekimoto</surname><given-names>M</given-names></name>
<name><surname>Tomita</surname><given-names>N</given-names></name>
<name><surname>Shiozaki</surname><given-names>H</given-names></name>
<name><surname>Monden</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="1998">1998</year><article-title>Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections</article-title><source>Journal of Histochemistry &#x00026; Cytochemistry</source><volume>46</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1177/002215549804600314</pub-id><pub-id pub-id-type="pmid">9487122</pub-id>
</element-citation></ref><ref id="ref-66"><label>Ikuta et al. (1989)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ikuta</surname><given-names>K</given-names></name>
<name><surname>Morita</surname><given-names>C</given-names></name>
<name><surname>Miyake</surname><given-names>S</given-names></name>
<name><surname>Ito</surname><given-names>T</given-names></name>
<name><surname>Okabayashi</surname><given-names>M</given-names></name>
<name><surname>Sano</surname><given-names>K</given-names></name>
<name><surname>Nakai</surname><given-names>M</given-names></name>
<name><surname>Hirai</surname><given-names>K</given-names></name>
<name><surname>Kato</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="1989">1989</year><article-title>Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens</article-title><source>Virology</source><volume>170</volume><fpage>408</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(89)90431-5</pub-id><pub-id pub-id-type="pmid">2499113</pub-id>
</element-citation></ref><ref id="ref-67"><label>Jenner et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jenner</surname><given-names>WJ</given-names></name>
<name><surname>Kanji</surname><given-names>R</given-names></name>
<name><surname>Mirsadraee</surname><given-names>S</given-names></name>
<name><surname>Gue</surname><given-names>YX</given-names></name>
<name><surname>Price</surname><given-names>S</given-names></name>
<name><surname>Prasad</surname><given-names>S</given-names></name>
<name><surname>Gorog</surname><given-names>DA</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review</article-title><source>Journal of Thrombosis and Thrombolysis</source><volume>51</volume><issue>3</issue><fpage>595</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1007/s11239-021-02394-7</pub-id><pub-id pub-id-type="pmid">33586113</pub-id>
</element-citation></ref><ref id="ref-68"><label>Jumper et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jumper</surname><given-names>J</given-names></name>
<name><surname>Evans</surname><given-names>R</given-names></name>
<name><surname>Pritzel</surname><given-names>A</given-names></name>
<name><surname>Green</surname><given-names>T</given-names></name>
<name><surname>Figurnov</surname><given-names>M</given-names></name>
<name><surname>Ronneberger</surname><given-names>O</given-names></name>
<name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name>
<name><surname>Bates</surname><given-names>R</given-names></name>
<name><surname>&#x0017d;&#x000ed;dek</surname><given-names>A</given-names></name>
<name><surname>Potapenko</surname><given-names>A</given-names></name>
<name><surname>Bridgland</surname><given-names>A</given-names></name>
<name><surname>Meyer C</surname></name>
<name><surname>Kohl</surname><given-names>SAA</given-names></name>
<name><surname>Ballard</surname><given-names>AJ</given-names></name>
<name><surname>Cowie</surname><given-names>A</given-names></name>
<name><surname>Romera-Paredes</surname><given-names>B</given-names></name>
<name><surname>Nikolov</surname><given-names>S</given-names></name>
<name><surname>Jain</surname><given-names>R</given-names></name>
<name><surname>Adler</surname><given-names>J</given-names></name>
<name><surname>Back</surname><given-names>T</given-names></name>
<name><surname>Petersen</surname><given-names>S</given-names></name>
<name><surname>Reiman</surname><given-names>D</given-names></name>
<name><surname>Clancy</surname><given-names>E</given-names></name>
<name><surname>Zielinski</surname><given-names>M</given-names></name>
<name><surname>Steinegger</surname><given-names>M</given-names></name>
<name><surname>Pacholska</surname><given-names>M</given-names></name>
<name><surname>Berghammer</surname><given-names>T</given-names></name>
<name><surname>Bodenstein</surname><given-names>S</given-names></name>
<name><surname>Silver</surname><given-names>D</given-names></name>
<name><surname>Vinyals</surname><given-names>O</given-names></name>
<name><surname>Senior</surname><given-names>AW</given-names></name>
<name><surname>Kavukcuoglu</surname><given-names>K</given-names></name>
<name><surname>Kohli</surname><given-names>P</given-names></name>
<name><surname>Hassabis</surname><given-names>D</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id>
</element-citation></ref><ref id="ref-69"><label>Katsoularis et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Katsoularis</surname><given-names>I</given-names></name>
<name><surname>Fonseca-Rodr&#x000ed;guez</surname><given-names>O</given-names></name>
<name><surname>Farrington</surname><given-names>P</given-names></name>
<name><surname>Jerndal</surname><given-names>H</given-names></name>
<name><surname>Lundevaller</surname><given-names>EH</given-names></name>
<name><surname>Sund</surname><given-names>M</given-names></name>
<name><surname>Lindmark</surname><given-names>K</given-names></name>
<name><surname>Fors Connolly</surname><given-names>AM</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study</article-title><source>BMJ</source><volume>377</volume><elocation-id>e069590</elocation-id><pub-id pub-id-type="doi">10.1136/bmj-2021-069590</pub-id><pub-id pub-id-type="pmid">35387772</pub-id>
</element-citation></ref><ref id="ref-70"><label>Keane &#x00026; Giedroc (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keane</surname><given-names>SC</given-names></name>
<name><surname>Giedroc</surname><given-names>DP</given-names></name>
</person-group><year iso-8601-date="2013">2013</year><article-title>Solution structure of Mouse Hepatitis Virus (MHV) nsp3a and determinants of the interaction with MHV nucleocapsid (N) protein</article-title><source>Journal of Virology</source><volume>87</volume><fpage>3502</fpage><lpage>3515</lpage><pub-id pub-id-type="doi">10.1128/JVI.03112-12</pub-id><pub-id pub-id-type="pmid">23302895</pub-id>
</element-citation></ref><ref id="ref-71"><label>Knight et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Knight</surname><given-names>R</given-names></name>
<name><surname>Walker</surname><given-names>V</given-names></name>
<name><surname>Ip</surname><given-names>S</given-names></name>
<name><surname>Cooper</surname><given-names>JA</given-names></name>
<name><surname>Bolton</surname><given-names>T</given-names></name>
<name><surname>Keene</surname><given-names>S</given-names></name>
<name><surname>Denholm</surname><given-names>R</given-names></name>
<name><surname>Akbari</surname><given-names>A</given-names></name>
<name><surname>Abbasizanjani</surname><given-names>H</given-names></name>
<name><surname>Torabi</surname><given-names>F</given-names></name>
<name><surname>Omigie</surname><given-names>E</given-names></name>
<name><surname>Hollings</surname><given-names>S</given-names></name>
<name><surname>North</surname><given-names>TL</given-names></name>
<name><surname>Toms</surname><given-names>R</given-names></name>
<name><surname>Jiang</surname><given-names>X</given-names></name>
<name><surname>Angelantonio</surname><given-names>ED</given-names></name>
<name><surname>Denaxas</surname><given-names>S</given-names></name>
<name><surname>Thygesen</surname><given-names>JH</given-names></name>
<name><surname>Tomlinson</surname><given-names>C</given-names></name>
<name><surname>Bray</surname><given-names>B</given-names></name>
<name><surname>Smith</surname><given-names>CJ</given-names></name>
<name><surname>Barber</surname><given-names>M</given-names></name>
<name><surname>Khunti</surname><given-names>K</given-names></name>
<name><surname>Davey Smith</surname><given-names>G</given-names></name>
<name><surname>Chaturvedi</surname><given-names>N</given-names></name>
<name><surname>Sudlow</surname><given-names>C</given-names></name>
<name><surname>Whiteley</surname><given-names>WN</given-names></name>
<name><surname>Wood</surname><given-names>AM</given-names></name>
<name><surname>Sterne</surname><given-names>JAC</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales</article-title><source>Circulation</source><volume>146</volume><issue>12</issue><fpage>892</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.060785</pub-id><pub-id pub-id-type="pmid">36121907</pub-id>
</element-citation></ref><ref id="ref-72"><label>Kuo &#x00026; Masters (2002)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuo</surname><given-names>L</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2002">2002</year><article-title>Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus</article-title><source>Journal of Virology</source><volume>76</volume><fpage>4987</fpage><lpage>4999</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.10.4987-4999.2002</pub-id><pub-id pub-id-type="pmid">11967315</pub-id>
</element-citation></ref><ref id="ref-73"><label>LaMere et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>LaMere</surname><given-names>MW</given-names></name>
<name><surname>Lam</surname><given-names>H-T</given-names></name>
<name><surname>Moquin</surname><given-names>A</given-names></name>
<name><surname>Haynes</surname><given-names>L</given-names></name>
<name><surname>Lund</surname><given-names>FE</given-names></name>
<name><surname>Randall</surname><given-names>TD</given-names></name>
<name><surname>Kaminski</surname><given-names>DA</given-names></name>
</person-group><year iso-8601-date="2011">2011</year><article-title>Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus</article-title><source>The Journal of Immunology</source><volume>186</volume><fpage>4331</fpage><lpage>4339</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003057</pub-id><pub-id pub-id-type="pmid">21357542</pub-id>
</element-citation></ref><ref id="ref-74"><label>Leung et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leung</surname><given-names>DTM</given-names></name>
<name><surname>Tam</surname><given-names>FCH</given-names></name>
<name><surname>Ma</surname><given-names>CH</given-names></name>
<name><surname>Chan</surname><given-names>PKS</given-names></name>
<name><surname>Cheung</surname><given-names>JLK</given-names></name>
<name><surname>Niu</surname><given-names>H</given-names></name>
<name><surname>Tam</surname><given-names>JSL</given-names></name>
<name><surname>Lim</surname><given-names>PL</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Antibody response of patients with Severe Acute Respiratory Syndrome (SARS) targets the viral nucleocapsid</article-title><source>The Journal of Infectious Diseases</source><volume>190</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1086/422040</pub-id><pub-id pub-id-type="pmid">15216476</pub-id>
</element-citation></ref><ref id="ref-75"><label>Li &#x00026; Li (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>D</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Immunologic testing for SARS-CoV-2 infection from the antigen perspective</article-title><source>Journal of Clinical Microbiology</source><volume>59</volume><elocation-id>e02160-20</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.02160-20</pub-id><pub-id pub-id-type="pmid">33318065</pub-id>
</element-citation></ref><ref id="ref-76"><label>Li et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J-Y</given-names></name>
<name><surname>Liao</surname><given-names>C-H</given-names></name>
<name><surname>Wang</surname><given-names>Q</given-names></name>
<name><surname>Tan</surname><given-names>Y-J</given-names></name>
<name><surname>Luo</surname><given-names>R</given-names></name>
<name><surname>Qiu</surname><given-names>Y</given-names></name>
<name><surname>Ge</surname><given-names>X-Y</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway</article-title><source>Virus Research</source><volume>286</volume><elocation-id>198074</elocation-id><pub-id pub-id-type="doi">10.1016/j.virusres.2020.198074</pub-id><pub-id pub-id-type="pmid">32589897</pub-id>
</element-citation></ref><ref id="ref-77"><label>Liu et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X</given-names></name>
<name><surname>Verma</surname><given-names>A</given-names></name>
<name><surname>Garcia</surname><given-names>G</given-names></name>
<name><surname>Ramage</surname><given-names>H</given-names></name>
<name><surname>Lucas</surname><given-names>A</given-names></name>
<name><surname>Myers</surname><given-names>RL</given-names></name>
<name><surname>Michaelson</surname><given-names>JJ</given-names></name>
<name><surname>Coryell</surname><given-names>W</given-names></name>
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Charney</surname><given-names>AW</given-names></name>
<name><surname>Kazanietz</surname><given-names>MG</given-names></name>
<name><surname>Rader</surname><given-names>DJ</given-names></name>
<name><surname>Ritchie</surname><given-names>MD</given-names></name>
<name><surname>Berrettini</surname><given-names>WH</given-names></name>
<name><surname>Schultz</surname><given-names>DC</given-names></name>
<name><surname>Cherry</surname><given-names>S</given-names></name>
<name><surname>Damoiseaux</surname><given-names>R</given-names></name>
<name><surname>Arumugaswami</surname><given-names>V</given-names></name>
<name><surname>Klein</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>118</volume><elocation-id>e2113401118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2113401118</pub-id><pub-id pub-id-type="pmid">34593624</pub-id>
</element-citation></ref><ref id="ref-78"><label>Long et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Long</surname><given-names>Q-X</given-names></name>
<name><surname>Liu</surname><given-names>B-Z</given-names></name>
<name><surname>Deng</surname><given-names>H-J</given-names></name>
<name><surname>Wu</surname><given-names>G-C</given-names></name>
<name><surname>Deng</surname><given-names>K</given-names></name>
<name><surname>Chen</surname><given-names>Y-K</given-names></name>
<name><surname>Liao</surname><given-names>P</given-names></name>
<name><surname>Qiu</surname><given-names>J-F</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Cai</surname><given-names>X-F</given-names></name>
<name><surname>Wang</surname><given-names>D-Q</given-names></name>
<name><surname>Hu</surname><given-names>Y</given-names></name>
<name><surname>Ren</surname><given-names>J-H</given-names></name>
<name><surname>Tang</surname><given-names>N</given-names></name>
<name><surname>Xu</surname><given-names>Y-Y</given-names></name>
<name><surname>Yu</surname><given-names>L-H</given-names></name>
<name><surname>Mo</surname><given-names>Z</given-names></name>
<name><surname>Gong</surname><given-names>F</given-names></name>
<name><surname>Zhang</surname><given-names>X-L</given-names></name>
<name><surname>Tian</surname><given-names>W-G</given-names></name>
<name><surname>Hu</surname><given-names>L</given-names></name>
<name><surname>Zhang</surname><given-names>X-X</given-names></name>
<name><surname>Xiang</surname><given-names>J-L</given-names></name>
<name><surname>Du</surname><given-names>H-X</given-names></name>
<name><surname>Liu</surname><given-names>H-W</given-names></name>
<name><surname>Lang</surname><given-names>C-H</given-names></name>
<name><surname>Luo</surname><given-names>X-H</given-names></name>
<name><surname>Wu</surname><given-names>S-B</given-names></name>
<name><surname>Cui</surname><given-names>X-P</given-names></name>
<name><surname>Zhou</surname><given-names>Z</given-names></name>
<name><surname>Zhu</surname><given-names>M-M</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Xue</surname><given-names>C-J</given-names></name>
<name><surname>Li</surname><given-names>X-F</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>Z-J</given-names></name>
<name><surname>Wang</surname><given-names>K</given-names></name>
<name><surname>Niu</surname><given-names>C-C</given-names></name>
<name><surname>Yang</surname><given-names>Q-J</given-names></name>
<name><surname>Tang</surname><given-names>X-J</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>X-M</given-names></name>
<name><surname>Li</surname><given-names>J-J</given-names></name>
<name><surname>Zhang</surname><given-names>D-C</given-names></name>
<name><surname>Zhang</surname><given-names>F</given-names></name>
<name><surname>Liu</surname><given-names>P</given-names></name>
<name><surname>Yuan</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<name><surname>Hu</surname><given-names>J-L</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Huang</surname><given-names>A-L</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Antibody responses to SARS-CoV-2 in patients with COVID-19</article-title><source>Nature Medicine</source><volume>26</volume><fpage>845</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0897-1</pub-id></element-citation></ref><ref id="ref-79"><label>Lopez et al. (1994)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez</surname><given-names>S</given-names></name>
<name><surname>Yao</surname><given-names>JS</given-names></name>
<name><surname>Kuhn</surname><given-names>RJ</given-names></name>
<name><surname>Strauss</surname><given-names>EG</given-names></name>
<name><surname>Strauss</surname><given-names>JH</given-names></name>
</person-group><year iso-8601-date="1994">1994</year><article-title>Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses</article-title><source>Journal of Virology</source><volume>68</volume><fpage>1316</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1128/jvi.68.3.1316-1323.1994</pub-id><pub-id pub-id-type="pmid">7508993</pub-id>
</element-citation></ref><ref id="ref-80"><label>L&#x000f3;pez-Mu&#x000f1;oz et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez-Mu&#x000f1;oz</surname><given-names>AD</given-names></name>
<name><surname>Kosik</surname><given-names>I</given-names></name>
<name><surname>Holly</surname><given-names>J</given-names></name>
<name><surname>Yewdell</surname><given-names>JW</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabp9770</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abp9770</pub-id><pub-id pub-id-type="pmid">35921414</pub-id>
</element-citation></ref><ref id="ref-81"><label>L&#x000f3;pez-Mu&#x000f1;oz, Santos &#x00026; Yewdell (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez-Mu&#x000f1;oz</surname><given-names>AD</given-names></name>
<name><surname>Santos</surname><given-names>JJS</given-names></name>
<name><surname>Yewdell</surname><given-names>JW</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>Cell surface nucleocapsid protein expression: a betacoronavirus immunomodulatory strategy</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>120</volume><elocation-id>e2304087120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2304087120</pub-id><pub-id pub-id-type="pmid">37399385</pub-id>
</element-citation></ref><ref id="ref-82"><label>Lu et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>R</given-names></name>
<name><surname>Zhao</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Niu</surname><given-names>P</given-names></name>
<name><surname>Yang</surname><given-names>B</given-names></name>
<name><surname>Wu</surname><given-names>H</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Song</surname><given-names>H</given-names></name>
<name><surname>Huang</surname><given-names>B</given-names></name>
<name><surname>Zhu</surname><given-names>N</given-names></name>
<name><surname>Bi</surname><given-names>Y</given-names></name>
<name><surname>Ma</surname><given-names>X</given-names></name>
<name><surname>Zhan</surname><given-names>F</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Hu</surname><given-names>T</given-names></name>
<name><surname>Zhou</surname><given-names>H</given-names></name>
<name><surname>Hu</surname><given-names>Z</given-names></name>
<name><surname>Zhou</surname><given-names>W</given-names></name>
<name><surname>Zhao</surname><given-names>L</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Meng</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Yuan</surname><given-names>J</given-names></name>
<name><surname>Xie</surname><given-names>Z</given-names></name>
<name><surname>Ma</surname><given-names>J</given-names></name>
<name><surname>Liu</surname><given-names>WJ</given-names></name>
<name><surname>Wang</surname><given-names>D</given-names></name>
<name><surname>Xu</surname><given-names>W</given-names></name>
<name><surname>Holmes</surname><given-names>EC</given-names></name>
<name><surname>Gao</surname><given-names>GF</given-names></name>
<name><surname>Wu</surname><given-names>G</given-names></name>
<name><surname>Chen</surname><given-names>W</given-names></name>
<name><surname>Shi</surname><given-names>W</given-names></name>
<name><surname>Tan</surname><given-names>W</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title><source>The Lancet</source><volume>395</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id></element-citation></ref><ref id="ref-83"><label>Lundstrom et al. (2023a)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lundstrom</surname><given-names>K</given-names></name>
<name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>A</given-names></name>
<name><surname>Bilajac</surname><given-names>E</given-names></name>
<name><surname>Aljabali</surname><given-names>AAA</given-names></name>
<name><surname>Barali&#x00107;</surname><given-names>K</given-names></name>
<name><surname>Sabri</surname><given-names>NA</given-names></name>
<name><surname>Shehata</surname><given-names>EM</given-names></name>
<name><surname>Raslan</surname><given-names>M</given-names></name>
<name><surname>Ferreira</surname><given-names>ACBH</given-names></name>
<name><surname>Orlandi</surname><given-names>L</given-names></name>
<name><surname>Serrano-Aroca</surname><given-names>&#x000c1;</given-names></name>
<name><surname>Tambuwala</surname><given-names>MM</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
<name><surname>Azevedo</surname><given-names>V</given-names></name>
<name><surname>Alzahrani</surname><given-names>KJ</given-names></name>
<name><surname>Alsharif</surname><given-names>KF</given-names></name>
<name><surname>Halawani</surname><given-names>IF</given-names></name>
<name><surname>Alzahrani</surname><given-names>FM</given-names></name>
<name><surname>Redwan</surname><given-names>EM</given-names></name>
<name><surname>Barh</surname><given-names>D</given-names></name>
</person-group><year iso-8601-date="2023">2023a</year><article-title>COVID-19 signalome: pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity</article-title><source>Cellular Signalling</source><volume>101</volume><elocation-id>110495</elocation-id><pub-id pub-id-type="doi">10.1016/j.cellsig.2022.110495</pub-id><pub-id pub-id-type="pmid">36252792</pub-id>
</element-citation></ref><ref id="ref-84"><label>Lundstrom et al. (2023b)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lundstrom</surname><given-names>K</given-names></name>
<name><surname>Hromi&#x00107;-Jahjefendi&#x00107;</surname><given-names>A</given-names></name>
<name><surname>Bilajac</surname><given-names>E</given-names></name>
<name><surname>Aljabali</surname><given-names>AAA</given-names></name>
<name><surname>Barali&#x00107;</surname><given-names>K</given-names></name>
<name><surname>Sabri</surname><given-names>NA</given-names></name>
<name><surname>Shehata</surname><given-names>EM</given-names></name>
<name><surname>Raslan</surname><given-names>M</given-names></name>
<name><surname>Raslan</surname><given-names>SA</given-names></name>
<name><surname>Ferreira</surname><given-names>ACBH</given-names></name>
<name><surname>Orlandi</surname><given-names>L</given-names></name>
<name><surname>Serrano-Aroca</surname><given-names>&#x000c1;</given-names></name>
<name><surname>Uversky</surname><given-names>VN</given-names></name>
<name><surname>Hassan</surname><given-names>SKS</given-names></name>
<name><surname>Redwan</surname><given-names>EM</given-names></name>
<name><surname>Azevedo</surname><given-names>V</given-names></name>
<name><surname>Alzahrani</surname><given-names>KJ</given-names></name>
<name><surname>Alsharif</surname><given-names>KF</given-names></name>
<name><surname>Halawani</surname><given-names>IF</given-names></name>
<name><surname>Alzahrani</surname><given-names>FM</given-names></name>
<name><surname>Tambuwala</surname><given-names>MM</given-names></name>
<name><surname>Barh</surname><given-names>D</given-names></name>
</person-group><year iso-8601-date="2023">2023b</year><article-title>COVID-19 signalome: potential therapeutic interventions</article-title><source>Cellular Signalling</source><volume>103</volume><elocation-id>110559</elocation-id><pub-id pub-id-type="doi">10.1016/j.cellsig.2022.110559</pub-id><pub-id pub-id-type="pmid">36521656</pub-id>
</element-citation></ref><ref id="ref-85"><label>Macnaughton, Davies &#x00026; Nermut (1978)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Macnaughton</surname><given-names>MR</given-names></name>
<name><surname>Davies</surname><given-names>HA</given-names></name>
<name><surname>Nermut</surname><given-names>MV</given-names></name>
</person-group><year iso-8601-date="1978">1978</year><article-title>Ribonucleoprotein-like structures from coronavirus particles</article-title><source>Journal of General Virology</source><volume>39</volume><fpage>545</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-39-3-545</pub-id><pub-id pub-id-type="pmid">207820</pub-id>
</element-citation></ref><ref id="ref-86"><label>Mai et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mai</surname><given-names>J</given-names></name>
<name><surname>Virtue</surname><given-names>A</given-names></name>
<name><surname>Shen</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Yang</surname><given-names>X-F</given-names></name>
</person-group><year iso-8601-date="2013">2013</year><article-title>An evolving new paradigm: endothelial cells &#x02013;conditional innate immune cells</article-title><source>Journal of Hematology &#x00026; Oncology</source><volume>6</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/1756-8722-6-61</pub-id><pub-id pub-id-type="pmid">23965413</pub-id>
</element-citation></ref><ref id="ref-87"><label>Marie et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marie</surname><given-names>JC</given-names></name>
<name><surname>Saltel</surname><given-names>F</given-names></name>
<name><surname>Escola</surname><given-names>J-M</given-names></name>
<name><surname>Jurdic</surname><given-names>P</given-names></name>
<name><surname>Wild</surname><given-names>TF</given-names></name>
<name><surname>Horvat</surname><given-names>B</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression</article-title><source>Journal of Virology</source><volume>78</volume><fpage>11952</fpage><lpage>11961</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.21.11952-11961.2004</pub-id><pub-id pub-id-type="pmid">15479835</pub-id>
</element-citation></ref><ref id="ref-88"><label>Masters et al. (1994)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Masters</surname><given-names>PS</given-names></name>
<name><surname>Koetzner</surname><given-names>CA</given-names></name>
<name><surname>Kerr</surname><given-names>CA</given-names></name>
<name><surname>Heo</surname><given-names>Y</given-names></name>
</person-group><year iso-8601-date="1994">1994</year><article-title>Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus</article-title><source>Journal of Virology</source><volume>68</volume><fpage>328</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1128/jvi.68.1.328-337.1994</pub-id><pub-id pub-id-type="pmid">8254744</pub-id>
</element-citation></ref><ref id="ref-89"><label>McBride, Van Zyl &#x00026; Fielding (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>R</given-names></name>
<name><surname>Van Zyl</surname><given-names>M</given-names></name>
<name><surname>Fielding</surname><given-names>BC</given-names></name>
</person-group><year iso-8601-date="2014">2014</year><article-title>The coronavirus nucleocapsid is a multifunctional protein</article-title><source>Viruses</source><volume>6</volume><fpage>2991</fpage><lpage>3018</lpage><pub-id pub-id-type="doi">10.3390/v6082991</pub-id><pub-id pub-id-type="pmid">25105276</pub-id>
</element-citation></ref><ref id="ref-90"><label>McFadyen, Stevens &#x00026; Peter (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McFadyen</surname><given-names>JD</given-names></name>
<name><surname>Stevens</surname><given-names>H</given-names></name>
<name><surname>Peter</surname><given-names>K</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications</article-title><source>Circulation Research</source><volume>127</volume><fpage>571</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.317447</pub-id><pub-id pub-id-type="pmid">32586214</pub-id>
</element-citation></ref><ref id="ref-91"><label>Mizurini et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mizurini</surname><given-names>DM</given-names></name>
<name><surname>Hottz</surname><given-names>ED</given-names></name>
<name><surname>Bozza</surname><given-names>PT</given-names></name>
<name><surname>Monteiro</surname><given-names>RQ</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Fundamentals in COVID-19-associated thrombosis: molecular and cellular aspects</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>785738</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.785738</pub-id><pub-id pub-id-type="pmid">34977191</pub-id>
</element-citation></ref><ref id="ref-92"><label>Mohd Faizal et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohd Faizal</surname><given-names>AS</given-names></name>
<name><surname>Hon</surname><given-names>WY</given-names></name>
<name><surname>Thevarajah</surname><given-names>TM</given-names></name>
<name><surname>Khor</surname><given-names>SM</given-names></name>
<name><surname>Chang</surname><given-names>S-W</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>A biomarker discovery of acute myocardial infarction using feature selection and machine learning</article-title><source>Medical &#x00026; Biological Engineering &#x00026; Computing</source><volume>61</volume><fpage>2527</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1007/s11517-023-02841-y</pub-id><pub-id pub-id-type="pmid">37199891</pub-id>
</element-citation></ref><ref id="ref-93"><label>Mu et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mu</surname><given-names>J</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Shu</surname><given-names>T</given-names></name>
<name><surname>Wu</surname><given-names>D</given-names></name>
<name><surname>Huang</surname><given-names>M</given-names></name>
<name><surname>Ren</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Geng</surname><given-names>Q</given-names></name>
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Qiu</surname><given-names>Y</given-names></name>
<name><surname>Zhou</surname><given-names>X</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells</article-title><source>Science China Life Sciences</source><volume>63</volume><fpage>1413</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1007/s11427-020-1692-1</pub-id><pub-id pub-id-type="pmid">32291557</pub-id>
</element-citation></ref><ref id="ref-94"><label>Munier, Ottmann &#x00026; Perry (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Munier</surname><given-names>CC</given-names></name>
<name><surname>Ottmann</surname><given-names>C</given-names></name>
<name><surname>Perry</surname><given-names>MWD</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>14-3-3 modulation of the inflammatory response</article-title><source>Pharmacological Research</source><volume>163</volume><elocation-id>105236</elocation-id><pub-id pub-id-type="doi">10.1016/j.phrs.2020.105236</pub-id><pub-id pub-id-type="pmid">33053447</pub-id>
</element-citation></ref><ref id="ref-95"><label>Murakami et al. (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murakami</surname><given-names>M</given-names></name>
<name><surname>Nguyen</surname><given-names>LT</given-names></name>
<name><surname>Zhang</surname><given-names>ZW</given-names></name>
<name><surname>Moodie</surname><given-names>KL</given-names></name>
<name><surname>Carmeliet</surname><given-names>P</given-names></name>
<name><surname>Stan</surname><given-names>RV</given-names></name>
<name><surname>Simons</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2008">2008</year><article-title>The FGF system has a key role in regulating vascular integrity</article-title><source>Journal of Clinical Investigation</source><volume>118</volume><fpage>3355</fpage><lpage>3366</lpage><pub-id pub-id-type="doi">10.1172/JCI35298</pub-id><pub-id pub-id-type="pmid">18776942</pub-id>
</element-citation></ref><ref id="ref-96"><label>Narayanan et al. (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narayanan</surname><given-names>K</given-names></name>
<name><surname>Chen</surname><given-names>C-J</given-names></name>
<name><surname>Maeda</surname><given-names>J</given-names></name>
<name><surname>Makino</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2003">2003</year><article-title>Nucleocapsid-independent specific viral RNA packaging <italic toggle="yes">via</italic> viral envelope protein and viral RNA signal</article-title><source>Journal of Virology</source><volume>77</volume><fpage>2922</fpage><lpage>2927</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.5.2922-2927.2003</pub-id><pub-id pub-id-type="pmid">12584316</pub-id>
</element-citation></ref><ref id="ref-97"><label>Narayanan, Kim &#x00026; Makino (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narayanan</surname><given-names>K</given-names></name>
<name><surname>Kim</surname><given-names>KH</given-names></name>
<name><surname>Makino</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2003">2003</year><article-title>Characterization of N protein self-association in coronavirus ribonucleoprotein complexes</article-title><source>Virus Research</source><volume>98</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2003.08.021</pub-id><pub-id pub-id-type="pmid">14659560</pub-id>
</element-citation></ref><ref id="ref-98"><label>Narayanan et al. (2000)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narayanan</surname><given-names>K</given-names></name>
<name><surname>Maeda</surname><given-names>A</given-names></name>
<name><surname>Maeda</surname><given-names>J</given-names></name>
<name><surname>Makino</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2000">2000</year><article-title>Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells</article-title><source>Journal of Virology</source><volume>74</volume><fpage>8127</fpage><lpage>8134</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.17.8127-8134.2000</pub-id><pub-id pub-id-type="pmid">10933723</pub-id>
</element-citation></ref><ref id="ref-99"><label>Nassar et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nassar</surname><given-names>M</given-names></name>
<name><surname>Daoud</surname><given-names>A</given-names></name>
<name><surname>Nso</surname><given-names>N</given-names></name>
<name><surname>Medina</surname><given-names>L</given-names></name>
<name><surname>Ghernautan</surname><given-names>V</given-names></name>
<name><surname>Bhangoo</surname><given-names>H</given-names></name>
<name><surname>Nyein</surname><given-names>A</given-names></name>
<name><surname>Mohamed</surname><given-names>M</given-names></name>
<name><surname>Alqassieh</surname><given-names>A</given-names></name>
<name><surname>Soliman</surname><given-names>K</given-names></name>
<name><surname>Alfishawy</surname><given-names>M</given-names></name>
<name><surname>Sachmechi</surname><given-names>I</given-names></name>
<name><surname>Misra</surname><given-names>A</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Diabetes mellitus and COVID-19: review article</article-title><source>Diabetes &#x00026; Metabolic Syndrome: Clinical Research &#x00026; Reviews</source><volume>15</volume><elocation-id>102268</elocation-id><pub-id pub-id-type="doi">10.1016/j.dsx.2021.102268</pub-id></element-citation></ref><ref id="ref-100"><label>Nelson, Stohlman &#x00026; Tahara (2000)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nelson</surname><given-names>GW</given-names></name>
<name><surname>Stohlman</surname><given-names>SA</given-names></name>
<name><surname>Tahara</surname><given-names>SM</given-names></name>
</person-group><year iso-8601-date="2000">2000</year><article-title>High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA</article-title><source>Microbiology</source><volume>81</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-1-181</pub-id></element-citation></ref><ref id="ref-101"><label>Orchard et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Orchard</surname><given-names>S</given-names></name>
<name><surname>Ammari</surname><given-names>M</given-names></name>
<name><surname>Aranda</surname><given-names>B</given-names></name>
<name><surname>Breuza</surname><given-names>L</given-names></name>
<name><surname>Briganti</surname><given-names>L</given-names></name>
<name><surname>Broackes-Carter</surname><given-names>F</given-names></name>
<name><surname>Campbell</surname><given-names>NH</given-names></name>
<name><surname>Chavali</surname><given-names>G</given-names></name>
<name><surname>Chen</surname><given-names>C</given-names></name>
<name><surname>del Toro</surname><given-names>N</given-names></name>
<name><surname>Duesbury</surname><given-names>M</given-names></name>
<name><surname>Dumousseau</surname><given-names>M</given-names></name>
<name><surname>Galeota</surname><given-names>E</given-names></name>
<name><surname>Hinz</surname><given-names>U</given-names></name>
<name><surname>Iannuccelli</surname><given-names>M</given-names></name>
<name><surname>Jagannathan</surname><given-names>S</given-names></name>
<name><surname>Jimenez</surname><given-names>R</given-names></name>
<name><surname>Khadake</surname><given-names>J</given-names></name>
<name><surname>Lagreid</surname><given-names>A</given-names></name>
<name><surname>Licata</surname><given-names>L</given-names></name>
<name><surname>Lovering</surname><given-names>RC</given-names></name>
<name><surname>Meldal</surname><given-names>B</given-names></name>
<name><surname>Melidoni</surname><given-names>AN</given-names></name>
<name><surname>Milagros</surname><given-names>M</given-names></name>
<name><surname>Peluso</surname><given-names>D</given-names></name>
<name><surname>Perfetto</surname><given-names>L</given-names></name>
<name><surname>Porras</surname><given-names>P</given-names></name>
<name><surname>Raghunath</surname><given-names>A</given-names></name>
<name><surname>Ricard-Blum</surname><given-names>S</given-names></name>
<name><surname>Roechert</surname><given-names>B</given-names></name>
<name><surname>Stutz</surname><given-names>A</given-names></name>
<name><surname>Tognolli</surname><given-names>M</given-names></name>
<name><surname>Van Roey</surname><given-names>K</given-names></name>
<name><surname>Cesareni</surname><given-names>G</given-names></name>
<name><surname>Hermjakob</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="2014">2014</year><article-title>The MIntAct project&#x02013;IntAct as a common curation platform for 11 molecular interaction databases</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>D358</fpage><lpage>D363</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1115</pub-id><pub-id pub-id-type="pmid">24234451</pub-id>
</element-citation></ref><ref id="ref-102"><label>Othman et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Othman</surname><given-names>HY</given-names></name>
<name><surname>Zaki</surname><given-names>IAH</given-names></name>
<name><surname>Isa</surname><given-names>MR</given-names></name>
<name><surname>Ming</surname><given-names>LC</given-names></name>
<name><surname>Zulkifly</surname><given-names>HH</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients</article-title><source>BMC Infectious Diseases</source><volume>24</volume><fpage>484</fpage><pub-id pub-id-type="doi">10.1186/s12879-024-09374-1</pub-id><pub-id pub-id-type="pmid">38730292</pub-id>
</element-citation></ref><ref id="ref-103"><label>Otifi &#x00026; Adiga (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Otifi</surname><given-names>HM</given-names></name>
<name><surname>Adiga</surname><given-names>BK</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Endothelial dysfunction in COVID-19 infection</article-title><source>The American Journal of the Medical Sciences</source><volume>363</volume><fpage>281</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.amjms.2021.12.010</pub-id><pub-id pub-id-type="pmid">35093394</pub-id>
</element-citation></ref><ref id="ref-104"><label>Peluso et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peluso</surname><given-names>MJ</given-names></name>
<name><surname>Deitchman</surname><given-names>AN</given-names></name>
<name><surname>Torres</surname><given-names>L</given-names></name>
<name><surname>Iyer</surname><given-names>NS</given-names></name>
<name><surname>Munter</surname><given-names>SE</given-names></name>
<name><surname>Nixon</surname><given-names>CC</given-names></name>
<name><surname>Donatelli</surname><given-names>J</given-names></name>
<name><surname>Thanh</surname><given-names>C</given-names></name>
<name><surname>Takahashi</surname><given-names>S</given-names></name>
<name><surname>Hakim</surname><given-names>J</given-names></name>
<name><surname>Turcios</surname><given-names>K</given-names></name>
<name><surname>Janson</surname><given-names>O</given-names></name>
<name><surname>Hoh</surname><given-names>R</given-names></name>
<name><surname>Tai</surname><given-names>V</given-names></name>
<name><surname>Hernandez</surname><given-names>Y</given-names></name>
<name><surname>Fehrman</surname><given-names>EA</given-names></name>
<name><surname>Spinelli</surname><given-names>MA</given-names></name>
<name><surname>Gandhi</surname><given-names>M</given-names></name>
<name><surname>Trinh</surname><given-names>L</given-names></name>
<name><surname>Wrin</surname><given-names>T</given-names></name>
<name><surname>Petropoulos</surname><given-names>CJ</given-names></name>
<name><surname>Aweeka</surname><given-names>FT</given-names></name>
<name><surname>Rodriguez-Barraquer</surname><given-names>I</given-names></name>
<name><surname>Kelly</surname><given-names>JD</given-names></name>
<name><surname>Martin</surname><given-names>JN</given-names></name>
<name><surname>Deeks</surname><given-names>SG</given-names></name>
<name><surname>Greenhouse</surname><given-names>B</given-names></name>
<name><surname>Rutishauser</surname><given-names>RL</given-names></name>
<name><surname>Henrich</surname><given-names>TJ</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109518</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109518</pub-id><pub-id pub-id-type="pmid">34358460</pub-id>
</element-citation></ref><ref id="ref-105"><label>Peng et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>Y</given-names></name>
<name><surname>Du</surname><given-names>N</given-names></name>
<name><surname>Lei</surname><given-names>Y</given-names></name>
<name><surname>Dorje</surname><given-names>S</given-names></name>
<name><surname>Qi</surname><given-names>J</given-names></name>
<name><surname>Luo</surname><given-names>T</given-names></name>
<name><surname>Gao</surname><given-names>GF</given-names></name>
<name><surname>Song</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e105938</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2020105938</pub-id><pub-id pub-id-type="pmid">32914439</pub-id>
</element-citation></ref><ref id="ref-106"><label>Perico, Benigni &#x00026; Remuzzi (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perico</surname><given-names>L</given-names></name>
<name><surname>Benigni</surname><given-names>A</given-names></name>
<name><surname>Remuzzi</surname><given-names>G</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>SARS-CoV-2 and the spike protein in endotheliopathy</article-title><source>Trends in Microbiology</source><volume>32</volume><fpage>53</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2023.06.004</pub-id><pub-id pub-id-type="pmid">37393180</pub-id>
</element-citation></ref><ref id="ref-107"><label>Pober &#x00026; Sessa (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pober</surname><given-names>JS</given-names></name>
<name><surname>Sessa</surname><given-names>WC</given-names></name>
</person-group><year iso-8601-date="2007">2007</year><article-title>Evolving functions of endothelial cells in inflammation</article-title><source>Nature Reviews Immunology</source><volume>7</volume><fpage>803</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1038/nri2171</pub-id></element-citation></ref><ref id="ref-108"><label>Qian et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qian</surname><given-names>Y</given-names></name>
<name><surname>Lei</surname><given-names>T</given-names></name>
<name><surname>Patel</surname><given-names>PS</given-names></name>
<name><surname>Lee</surname><given-names>CH</given-names></name>
<name><surname>Monaghan-Nichols</surname><given-names>P</given-names></name>
<name><surname>Xin</surname><given-names>H-B</given-names></name>
<name><surname>Qiu</surname><given-names>J</given-names></name>
<name><surname>Fu</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin</article-title><source>Journal of Virology</source><volume>95</volume><elocation-id>e0139621</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01396-21</pub-id><pub-id pub-id-type="pmid">34549987</pub-id>
</element-citation></ref><ref id="ref-109"><label>Risco et al. (1996)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Risco</surname><given-names>C</given-names></name>
<name><surname>Ant&#x000f3;n</surname><given-names>IM</given-names></name>
<name><surname>Enjuanes</surname><given-names>L</given-names></name>
<name><surname>Carrascosa</surname><given-names>JL</given-names></name>
</person-group><year iso-8601-date="1996">1996</year><article-title>The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins</article-title><source>Journal of Virology</source><volume>70</volume><fpage>4773</fpage><lpage>4777</lpage><pub-id pub-id-type="doi">10.1128/jvi.70.7.4773-4777.1996</pub-id><pub-id pub-id-type="pmid">8676505</pub-id>
</element-citation></ref><ref id="ref-110"><label>Robbins et al. (1986)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Robbins</surname><given-names>SG</given-names></name>
<name><surname>Frana</surname><given-names>MF</given-names></name>
<name><surname>McGowan</surname><given-names>JJ</given-names></name>
<name><surname>Boyle</surname><given-names>JF</given-names></name>
<name><surname>Holmest</surname><given-names>KV</given-names></name>
</person-group><year iso-8601-date="1986">1986</year><article-title>RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay</article-title><source>Virology</source><volume>150</volume><fpage>402</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(86)90305-3</pub-id><pub-id pub-id-type="pmid">3083580</pub-id>
</element-citation></ref><ref id="ref-111"><label>Sariol &#x00026; Perlman (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sariol</surname><given-names>A</given-names></name>
<name><surname>Perlman</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Lessons for COVID-19 immunity from other coronavirus infections</article-title><source>Immunity</source><volume>53</volume><fpage>248</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.07.005</pub-id><pub-id pub-id-type="pmid">32717182</pub-id>
</element-citation></ref><ref id="ref-112"><label>Savla, Prabhavalkar &#x00026; Bhatt (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Savla</surname><given-names>SR</given-names></name>
<name><surname>Prabhavalkar</surname><given-names>KS</given-names></name>
<name><surname>Bhatt</surname><given-names>LK</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Cytokine storm associated coagulation complications in COVID-19 patients: pathogenesis and Management</article-title><source>Expert Review of Anti-infective Therapy</source><volume>19</volume><fpage>1397</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1080/14787210.2021.1915129</pub-id><pub-id pub-id-type="pmid">33832398</pub-id>
</element-citation></ref><ref id="ref-113"><label>Sawicki, Sawicki &#x00026; Siddell (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sawicki</surname><given-names>SG</given-names></name>
<name><surname>Sawicki</surname><given-names>DL</given-names></name>
<name><surname>Siddell</surname><given-names>SG</given-names></name>
</person-group><year iso-8601-date="2007">2007</year><article-title>A contemporary view of coronavirus transcription</article-title><source>Journal of Virology</source><volume>81</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1128/JVI.01358-06</pub-id><pub-id pub-id-type="pmid">16928755</pub-id>
</element-citation></ref><ref id="ref-114"><label>Schelle et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schelle</surname><given-names>B</given-names></name>
<name><surname>Karl</surname><given-names>N</given-names></name>
<name><surname>Ludewig</surname><given-names>B</given-names></name>
<name><surname>Siddell</surname><given-names>SG</given-names></name>
<name><surname>Thiel</surname><given-names>V</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>Selective replication of coronavirus genomes that express nucleocapsid protein</article-title><source>Journal of Virology</source><volume>79</volume><fpage>6620</fpage><lpage>6630</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.11.6620-6630.2005</pub-id><pub-id pub-id-type="pmid">15890900</pub-id>
</element-citation></ref><ref id="ref-115"><label>Schr&#x000f6;dinger (2015)</label><element-citation publication-type="software"><person-group person-group-type="author">
<name><surname>Schr&#x000f6;dinger</surname><given-names>LLC</given-names></name>
</person-group><year iso-8601-date="2015">2015</year><data-title>The PyMOL molecular graphics system</data-title><version designator="1.8">Version 1.8</version><comment>
<uri xlink:href="https://cir.nii.ac.jp/crid/1370294643858081026">https://cir.nii.ac.jp/crid/1370294643858081026</uri>
</comment></element-citation></ref><ref id="ref-116"><label>Shao et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shao</surname><given-names>Y</given-names></name>
<name><surname>Saredy</surname><given-names>J</given-names></name>
<name><surname>Yang</surname><given-names>WY</given-names></name>
<name><surname>Sun</surname><given-names>Y</given-names></name>
<name><surname>Lu</surname><given-names>Y</given-names></name>
<name><surname>Saaoud</surname><given-names>F</given-names></name>
<name><surname>Drummer</surname><given-names>IVC</given-names></name>
<name><surname>Johnson</surname><given-names>C</given-names></name>
<name><surname>Xu</surname><given-names>K</given-names></name>
<name><surname>Jiang</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Yang</surname><given-names>X</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Vascular endothelial cells and innate immunity</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>40</volume><elocation-id>e138&#x02013;e152</elocation-id><pub-id pub-id-type="doi">10.1161/ATVBAHA.120.314330</pub-id><pub-id pub-id-type="pmid">32459541</pub-id>
</element-citation></ref><ref id="ref-117"><label>Shi et al. (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>Y</given-names></name>
<name><surname>Yi</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>P</given-names></name>
<name><surname>Kuang</surname><given-names>T</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Dong</surname><given-names>M</given-names></name>
<name><surname>Ma</surname><given-names>Q</given-names></name>
<name><surname>Cao</surname><given-names>C</given-names></name>
</person-group><year iso-8601-date="2003">2003</year><article-title>Diagnosis of Severe Acute Respiratory Syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay</article-title><source>Journal of Clinical Microbiology</source><volume>41</volume><fpage>5781</fpage><lpage>5782</lpage><pub-id pub-id-type="doi">10.1128/JCM.41.12.5781-5782.2003</pub-id><pub-id pub-id-type="pmid">14662982</pub-id>
</element-citation></ref><ref id="ref-118"><label>Sims, Ostermann &#x00026; Denison (2000)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sims</surname><given-names>AC</given-names></name>
<name><surname>Ostermann</surname><given-names>J</given-names></name>
<name><surname>Denison</surname><given-names>MR</given-names></name>
</person-group><year iso-8601-date="2000">2000</year><article-title>Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes</article-title><source>Journal of Virology</source><volume>74</volume><fpage>5647</fpage><lpage>5654</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.12.5647-5654.2000</pub-id><pub-id pub-id-type="pmid">10823872</pub-id>
</element-citation></ref><ref id="ref-119"><label>Spaan et al. (1981)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spaan</surname><given-names>WJM</given-names></name>
<name><surname>Rottier</surname><given-names>PJM</given-names></name>
<name><surname>Horzinek</surname><given-names>MC</given-names></name>
<name><surname>Van Der Zeijst</surname><given-names>BAM</given-names></name>
</person-group><year iso-8601-date="1981">1981</year><article-title>Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59)</article-title><source>Virology</source><volume>108</volume><fpage>424</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(81)90449-9</pub-id><pub-id pub-id-type="pmid">6258295</pub-id>
</element-citation></ref><ref id="ref-120"><label>Staerz, Yewdell &#x00026; Bevan (1987)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Staerz</surname><given-names>UD</given-names></name>
<name><surname>Yewdell</surname><given-names>JW</given-names></name>
<name><surname>Bevan</surname><given-names>MJ</given-names></name>
</person-group><year iso-8601-date="1987">1987</year><article-title>Hybrid antibody-mediated lysis of virus-infected cells</article-title><source>European Journal of Immunology</source><volume>17</volume><fpage>571</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1002/eji.1830170422</pub-id><pub-id pub-id-type="pmid">3494618</pub-id>
</element-citation></ref><ref id="ref-121"><label>Stertz et al. (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stertz</surname><given-names>S</given-names></name>
<name><surname>Reichelt</surname><given-names>M</given-names></name>
<name><surname>Spiegel</surname><given-names>M</given-names></name>
<name><surname>Kuri</surname><given-names>T</given-names></name>
<name><surname>Mart&#x000ed;nez-Sobrido</surname><given-names>L</given-names></name>
<name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A</given-names></name>
<name><surname>Weber</surname><given-names>F</given-names></name>
<name><surname>Kochs</surname><given-names>G</given-names></name>
</person-group><year iso-8601-date="2007">2007</year><article-title>The intracellular sites of early replication and budding of SARS-coronavirus</article-title><source>Virology</source><volume>361</volume><fpage>304</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.11.027</pub-id><pub-id pub-id-type="pmid">17210170</pub-id>
</element-citation></ref><ref id="ref-122"><label>Straub et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Straub</surname><given-names>T</given-names></name>
<name><surname>Schweier</surname><given-names>O</given-names></name>
<name><surname>Bruns</surname><given-names>M</given-names></name>
<name><surname>Nimmerjahn</surname><given-names>F</given-names></name>
<name><surname>Waisman</surname><given-names>A</given-names></name>
<name><surname>Pircher</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="2013">2013</year><article-title>Nucleoprotein-specific nonneutralizing antibodies speed up <sc>LCMV</sc> elimination independently of complement and <sc>F</sc> c<italic toggle="yes">&#x003b3;</italic><sc>R</sc>
</article-title><source>European Journal of Immunology</source><volume>43</volume><fpage>2338</fpage><lpage>2348</lpage><pub-id pub-id-type="doi">10.1002/eji.201343565</pub-id><pub-id pub-id-type="pmid">23749409</pub-id>
</element-citation></ref><ref id="ref-123"><label>Sturman, Holmes &#x00026; Behnke (1980)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sturman</surname><given-names>LS</given-names></name>
<name><surname>Holmes</surname><given-names>KV</given-names></name>
<name><surname>Behnke</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="1980">1980</year><article-title>Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid</article-title><source>Journal of Virology</source><volume>33</volume><fpage>449</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1128/jvi.33.1.449-462.1980</pub-id><pub-id pub-id-type="pmid">6245243</pub-id>
</element-citation></ref><ref id="ref-124"><label>Stuwe et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stuwe</surname><given-names>H</given-names></name>
<name><surname>Reardon</surname><given-names>PN</given-names></name>
<name><surname>Yu</surname><given-names>Z</given-names></name>
<name><surname>Shah</surname><given-names>S</given-names></name>
<name><surname>Hughes</surname><given-names>K</given-names></name>
<name><surname>Barbar</surname><given-names>EJ</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Phosphorylation in the Ser/Arg-rich region of the nucleocapsid of SARS-CoV-2 regulates phase separation by inhibiting self-association of a distant helix</article-title><source>Journal of Biological Chemistry</source><volume>300</volume><elocation-id>107354</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2024.107354</pub-id><pub-id pub-id-type="pmid">38718862</pub-id>
</element-citation></ref><ref id="ref-125"><label>Su et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Su</surname><given-names>M</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>Qi</surname><given-names>S</given-names></name>
<name><surname>Shi</surname><given-names>D</given-names></name>
<name><surname>Feng</surname><given-names>L</given-names></name>
<name><surname>Sun</surname><given-names>D</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>A mini-review on cell cycle regulation of coronavirus infection</article-title><source>Frontiers in Veterinary Science</source><volume>7</volume><elocation-id>586826</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2020.586826</pub-id><pub-id pub-id-type="pmid">33251267</pub-id>
</element-citation></ref><ref id="ref-126"><label>Su et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Su</surname><given-names>Y</given-names></name>
<name><surname>Yuan</surname><given-names>D</given-names></name>
<name><surname>Chen</surname><given-names>DG</given-names></name>
<name><surname>Ng</surname><given-names>RH</given-names></name>
<name><surname>Wang</surname><given-names>K</given-names></name>
<name><surname>Choi</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>S</given-names></name>
<name><surname>Hong</surname><given-names>S</given-names></name>
<name><surname>Zhang</surname><given-names>R</given-names></name>
<name><surname>Xie</surname><given-names>J</given-names></name>
<name><surname>Kornilov</surname><given-names>SA</given-names></name>
<name><surname>Scherler</surname><given-names>K</given-names></name>
<name><surname>Pavlovitch-Bedzyk</surname><given-names>AJ</given-names></name>
<name><surname>Dong</surname><given-names>S</given-names></name>
<name><surname>Lausted</surname><given-names>C</given-names></name>
<name><surname>Lee</surname><given-names>I</given-names></name>
<name><surname>Fallen</surname><given-names>S</given-names></name>
<name><surname>Dai</surname><given-names>CL</given-names></name>
<name><surname>Baloni</surname><given-names>P</given-names></name>
<name><surname>Smith</surname><given-names>B</given-names></name>
<name><surname>Duvvuri</surname><given-names>VR</given-names></name>
<name><surname>Anderson</surname><given-names>KG</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Yang</surname><given-names>F</given-names></name>
<name><surname>Duncombe</surname><given-names>CJ</given-names></name>
<name><surname>McCulloch</surname><given-names>DJ</given-names></name>
<name><surname>Rostomily</surname><given-names>C</given-names></name>
<name><surname>Troisch</surname><given-names>P</given-names></name>
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Mackay</surname><given-names>S</given-names></name>
<name><surname>De Gottardi</surname><given-names>Q</given-names></name>
<name><surname>May</surname><given-names>DH</given-names></name>
<name><surname>Taniguchi</surname><given-names>R</given-names></name>
<name><surname>Gittelman</surname><given-names>RM</given-names></name>
<name><surname>Klinger</surname><given-names>M</given-names></name>
<name><surname>Snyder</surname><given-names>TM</given-names></name>
<name><surname>Roper</surname><given-names>R</given-names></name>
<name><surname>Wojciechowska</surname><given-names>G</given-names></name>
<name><surname>Murray</surname><given-names>K</given-names></name>
<name><surname>Edmark</surname><given-names>R</given-names></name>
<name><surname>Evans</surname><given-names>S</given-names></name>
<name><surname>Jones</surname><given-names>L</given-names></name>
<name><surname>Zhou</surname><given-names>Y</given-names></name>
<name><surname>Rowen</surname><given-names>L</given-names></name>
<name><surname>Liu</surname><given-names>R</given-names></name>
<name><surname>Chour</surname><given-names>W</given-names></name>
<name><surname>Algren</surname><given-names>HA</given-names></name>
<name><surname>Berrington</surname><given-names>WR</given-names></name>
<name><surname>Wallick</surname><given-names>JA</given-names></name>
<name><surname>Cochran</surname><given-names>RA</given-names></name>
<name><surname>Micikas</surname><given-names>ME</given-names></name>
<name><surname>Wrin</surname><given-names>T</given-names></name>
<name><surname>Petropoulos</surname><given-names>CJ</given-names></name>
<name><surname>Cole</surname><given-names>HR</given-names></name>
<name><surname>Fischer</surname><given-names>TD</given-names></name>
<name><surname>Wei</surname><given-names>W</given-names></name>
<name><surname>Hoon</surname><given-names>DSB</given-names></name>
<name><surname>Price</surname><given-names>ND</given-names></name>
<name><surname>Subramanian</surname><given-names>N</given-names></name>
<name><surname>Hill</surname><given-names>JA</given-names></name>
<name><surname>Hadlock</surname><given-names>J</given-names></name>
<name><surname>Magis</surname><given-names>AT</given-names></name>
<name><surname>Ribas</surname><given-names>A</given-names></name>
<name><surname>Lanier</surname><given-names>LL</given-names></name>
<name><surname>Boyd</surname><given-names>SD</given-names></name>
<name><surname>Bluestone</surname><given-names>JA</given-names></name>
<name><surname>Chu</surname><given-names>H</given-names></name>
<name><surname>Hood</surname><given-names>L</given-names></name>
<name><surname>Gottardo</surname><given-names>R</given-names></name>
<name><surname>Greenberg</surname><given-names>PD</given-names></name>
<name><surname>Davis</surname><given-names>MM</given-names></name>
<name><surname>Goldman</surname><given-names>JD</given-names></name>
<name><surname>Heath</surname><given-names>JR</given-names></name>
</person-group><year iso-8601-date="2022">2022</year><article-title>Multiple early factors anticipate post-acute COVID-19 sequelae</article-title><source>Cell</source><volume>185</volume><fpage>881</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.01.014</pub-id><pub-id pub-id-type="pmid">35216672</pub-id>
</element-citation></ref><ref id="ref-127"><label>Suomalainen, Liljestr&#x000f6;m &#x00026; Garoff (1992)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suomalainen</surname><given-names>M</given-names></name>
<name><surname>Liljestr&#x000f6;m</surname><given-names>P</given-names></name>
<name><surname>Garoff</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="1992">1992</year><article-title>Spike protein-nucleocapsid interactions drive the budding of alphaviruses</article-title><source>Journal of Virology</source><volume>66</volume><fpage>4737</fpage><lpage>4747</lpage><pub-id pub-id-type="doi">10.1128/jvi.66.8.4737-4747.1992</pub-id><pub-id pub-id-type="pmid">1629953</pub-id>
</element-citation></ref><ref id="ref-128"><label>Surjit et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Surjit</surname><given-names>M</given-names></name>
<name><surname>Kumar</surname><given-names>R</given-names></name>
<name><surname>Mishra</surname><given-names>RN</given-names></name>
<name><surname>Reddy</surname><given-names>MK</given-names></name>
<name><surname>Chow</surname><given-names>VTK</given-names></name>
<name><surname>Lal</surname><given-names>SK</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation</article-title><source>Journal of Virology</source><volume>79</volume><fpage>11476</fpage><lpage>11486</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.17.11476-11486.2005</pub-id><pub-id pub-id-type="pmid">16103198</pub-id>
</element-citation></ref><ref id="ref-129"><label>Surjit et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Surjit</surname><given-names>M</given-names></name>
<name><surname>Liu</surname><given-names>B</given-names></name>
<name><surname>Chow</surname><given-names>VTK</given-names></name>
<name><surname>Lal</surname><given-names>SK</given-names></name>
</person-group><year iso-8601-date="2006">2006</year><article-title>The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>10669</fpage><lpage>10681</lpage><pub-id pub-id-type="doi">10.1074/jbc.M509233200</pub-id><pub-id pub-id-type="pmid">16431923</pub-id>
</element-citation></ref><ref id="ref-130"><label>Surjit et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Surjit</surname><given-names>M</given-names></name>
<name><surname>Liu</surname><given-names>B</given-names></name>
<name><surname>Kumar</surname><given-names>P</given-names></name>
<name><surname>Chow</surname><given-names>VTK</given-names></name>
<name><surname>Lal</surname><given-names>SK</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain</article-title><source>Biochemical and Biophysical Research Communications</source><volume>317</volume><fpage>1030</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.03.154</pub-id><pub-id pub-id-type="pmid">15094372</pub-id>
</element-citation></ref><ref id="ref-131"><label>Talla et al. (2021)</label><element-citation publication-type="working-paper"><person-group person-group-type="author">
<name><surname>Talla</surname><given-names>A</given-names></name>
<name><surname>Vasaikar</surname><given-names>SV</given-names></name>
<name><surname>Lemos</surname><given-names>MP</given-names></name>
<name><surname>Moodie</surname><given-names>Z</given-names></name>
<name><surname>Lee Pebworth</surname><given-names>M-P</given-names></name>
<name><surname>Henderson</surname><given-names>KE</given-names></name>
<name><surname>Cohen</surname><given-names>KW</given-names></name>
<name><surname>Czartoski</surname><given-names>JL</given-names></name>
<name><surname>Lai</surname><given-names>L</given-names></name>
<name><surname>Suthar</surname><given-names>MS</given-names></name>
<name><surname>Heubeck</surname><given-names>AT</given-names></name>
<name><surname>Genge</surname><given-names>PC</given-names></name>
<name><surname>Roll</surname><given-names>CR</given-names></name>
<name><surname>Weiss</surname><given-names>M</given-names></name>
<name><surname>Reading</surname><given-names>J</given-names></name>
<name><surname>Kondza</surname><given-names>N</given-names></name>
<name><surname>MacMillan</surname><given-names>H</given-names></name>
<name><surname>Fong</surname><given-names>OC</given-names></name>
<name><surname>Thomson</surname><given-names>ZJ</given-names></name>
<name><surname>Graybuck</surname><given-names>LT</given-names></name>
<name><surname>Okada</surname><given-names>LY</given-names></name>
<name><surname>Newell</surname><given-names>EW</given-names></name>
<name><surname>Coffey</surname><given-names>EM</given-names></name>
<name><surname>Meijer</surname><given-names>P</given-names></name>
<name><surname>Becker</surname><given-names>LA</given-names></name>
<name><surname>De Rosa</surname><given-names>SC</given-names></name>
<name><surname>Skene</surname><given-names>PJ</given-names></name>
<name><surname>Torgerson</surname><given-names>TR</given-names></name>
<name><surname>Li</surname><given-names>X-J</given-names></name>
<name><surname>Szeto</surname><given-names>GL</given-names></name>
<name><surname>McElrath</surname><given-names>MJ</given-names></name>
<name><surname>Bumol</surname><given-names>TF</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence</article-title><source>bioRxiv: The Preprint Server for Biology</source><pub-id pub-id-type="doi">10.1101/2021.05.26.442666</pub-id></element-citation></ref><ref id="ref-132"><label>Tan et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>Y-J</given-names></name>
<name><surname>Goh</surname><given-names>P-Y</given-names></name>
<name><surname>Fielding</surname><given-names>BC</given-names></name>
<name><surname>Shen</surname><given-names>S</given-names></name>
<name><surname>Chou</surname><given-names>C-F</given-names></name>
<name><surname>Fu</surname><given-names>J-L</given-names></name>
<name><surname>Leong</surname><given-names>HN</given-names></name>
<name><surname>Leo</surname><given-names>YS</given-names></name>
<name><surname>Ooi</surname><given-names>EE</given-names></name>
<name><surname>Ling</surname><given-names>AE</given-names></name>
<name><surname>Lim</surname><given-names>SG</given-names></name>
<name><surname>Hong</surname><given-names>W</given-names></name>
</person-group><year iso-8601-date="2004">2004</year><article-title>Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers</article-title><source>Clinical and Vaccine Immunology</source><volume>11</volume><fpage>362</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1128/CDLI.11.2.362-371.2004</pub-id></element-citation></ref><ref id="ref-133"><label>Teuwen et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teuwen</surname><given-names>L-A</given-names></name>
<name><surname>Geldhof</surname><given-names>V</given-names></name>
<name><surname>Pasut</surname><given-names>A</given-names></name>
<name><surname>Carmeliet</surname><given-names>P</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19: the vasculature unleashed</article-title><source>Nature Reviews Immunology</source><volume>20</volume><fpage>389</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0343-0</pub-id></element-citation></ref><ref id="ref-134"><label>Thiel et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thiel</surname><given-names>V</given-names></name>
<name><surname>Herold</surname><given-names>J</given-names></name>
<name><surname>Schelle</surname><given-names>B</given-names></name>
<name><surname>Siddell</surname><given-names>SG</given-names></name>
</person-group><year iso-8601-date="2001">2001</year><article-title>Viral replicase gene products suffice for coronavirus discontinuous transcription</article-title><source>Journal of Virology</source><volume>75</volume><fpage>6676</fpage><lpage>6681</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.14.6676-6681.2001</pub-id><pub-id pub-id-type="pmid">11413334</pub-id>
</element-citation></ref><ref id="ref-135"><label>Tugaeva et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tugaeva</surname><given-names>KV</given-names></name>
<name><surname>Hawkins</surname><given-names>DEDP</given-names></name>
<name><surname>Smith</surname><given-names>JLR</given-names></name>
<name><surname>Bayfield</surname><given-names>OW</given-names></name>
<name><surname>Ker</surname><given-names>D-S</given-names></name>
<name><surname>Sysoev</surname><given-names>AA</given-names></name>
<name><surname>Klychnikov</surname><given-names>OI</given-names></name>
<name><surname>Antson</surname><given-names>AA</given-names></name>
<name><surname>Sluchanko</surname><given-names>NN</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins</article-title><source>Journal of Molecular Biology</source><volume>433</volume><elocation-id>166875</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2021.166875</pub-id><pub-id pub-id-type="pmid">33556408</pub-id>
</element-citation></ref><ref id="ref-136"><label>Valencia et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valencia</surname><given-names>I</given-names></name>
<name><surname>Lumpuy-Castillo</surname><given-names>J</given-names></name>
<name><surname>Magalhaes</surname><given-names>G</given-names></name>
<name><surname>S&#x000e1;nchez-Ferrer</surname><given-names>CF</given-names></name>
<name><surname>Lorenzo</surname><given-names>&#x000d3;</given-names></name>
<name><surname>Peir&#x000f3;</surname><given-names>C</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus</article-title><source>Cardiovascular Diabetology</source><volume>23</volume><fpage>75</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-02097-8</pub-id><pub-id pub-id-type="pmid">38378550</pub-id>
</element-citation></ref><ref id="ref-137"><label>Van Der Meer et al. (1999)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Der Meer</surname><given-names>Y</given-names></name>
<name><surname>Snijder</surname><given-names>EJ</given-names></name>
<name><surname>Dobbe</surname><given-names>JC</given-names></name>
<name><surname>Schleich</surname><given-names>S</given-names></name>
<name><surname>Denison</surname><given-names>MR</given-names></name>
<name><surname>Spaan</surname><given-names>WJM</given-names></name>
<name><surname>Locker</surname><given-names>JK</given-names></name>
</person-group><year iso-8601-date="1999">1999</year><article-title>Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication</article-title><source>Journal of Virology</source><volume>73</volume><fpage>7641</fpage><lpage>7657</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.9.7641-7657.1999</pub-id><pub-id pub-id-type="pmid">10438855</pub-id>
</element-citation></ref><ref id="ref-138"><label>Van Hinsbergh (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Hinsbergh</surname><given-names>VWM</given-names></name>
</person-group><year iso-8601-date="2012">2012</year><article-title>Endothelium&#x02014;role in regulation of coagulation and inflammation</article-title><source>Seminars in Immunopathology</source><volume>34</volume><fpage>93</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1007/s00281-011-0285-5</pub-id><pub-id pub-id-type="pmid">21845431</pub-id>
</element-citation></ref><ref id="ref-139"><label>Wang et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y-C</given-names></name>
<name><surname>Tsai</surname><given-names>C-H</given-names></name>
<name><surname>Wang</surname><given-names>Y-C</given-names></name>
<name><surname>Yen</surname><given-names>L-C</given-names></name>
<name><surname>Chang</surname><given-names>Y-W</given-names></name>
<name><surname>Sun</surname><given-names>J-R</given-names></name>
<name><surname>Lin</surname><given-names>T-Y</given-names></name>
<name><surname>Chiu</surname><given-names>C-H</given-names></name>
<name><surname>Chao</surname><given-names>Y-C</given-names></name>
<name><surname>Chang</surname><given-names>F-Y</given-names></name>
</person-group><year iso-8601-date="2024">2024</year><article-title>SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19</article-title><source>Infection</source><volume>52</volume><fpage>955</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1007/s15010-023-02142-4</pub-id><pub-id pub-id-type="pmid">38133713</pub-id>
</element-citation></ref><ref id="ref-140"><label>Wolinsky (1980)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wolinsky</surname><given-names>H</given-names></name>
</person-group><year iso-8601-date="1980">1980</year><article-title>A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis</article-title><source>Circulation Research</source><volume>47</volume><fpage>301</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1161/01.RES.47.3.301</pub-id><pub-id pub-id-type="pmid">6996862</pub-id>
</element-citation></ref><ref id="ref-141"><label>Wu et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>W</given-names></name>
<name><surname>Cheng</surname><given-names>Y</given-names></name>
<name><surname>Zhou</surname><given-names>H</given-names></name>
<name><surname>Sun</surname><given-names>C</given-names></name>
<name><surname>Zhang</surname><given-names>S</given-names></name>
</person-group><year iso-8601-date="2023">2023</year><article-title>The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics</article-title><source>Virology Journal</source><volume>20</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s12985-023-01968-6</pub-id><pub-id pub-id-type="pmid">36627683</pub-id>
</element-citation></ref><ref id="ref-142"><label>Xu et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>W</given-names></name>
<name><surname>Pei</surname><given-names>G</given-names></name>
<name><surname>Liu</surname><given-names>H</given-names></name>
<name><surname>Ju</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Ding</surname><given-names>Q</given-names></name>
<name><surname>Li</surname><given-names>P</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>109778</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109778</pub-id><pub-id pub-id-type="pmid">34686343</pub-id>
</element-citation></ref><ref id="ref-143"><label>Ye et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>Q</given-names></name>
<name><surname>West</surname><given-names>AMV</given-names></name>
<name><surname>Silletti</surname><given-names>S</given-names></name>
<name><surname>Corbett</surname><given-names>KD</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein</article-title><source>Protein Science: A Publication of the Protein Society</source><volume>29</volume><fpage>1890</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1002/pro.3909</pub-id><pub-id pub-id-type="pmid">32654247</pub-id>
</element-citation></ref><ref id="ref-144"><label>Yewdell et al. (1986)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yewdell</surname><given-names>JW</given-names></name>
<name><surname>Bennink</surname><given-names>JR</given-names></name>
<name><surname>Mackett</surname><given-names>M</given-names></name>
<name><surname>Lefrancois</surname><given-names>L</given-names></name>
<name><surname>Lyles</surname><given-names>DS</given-names></name>
<name><surname>Moss</surname><given-names>B</given-names></name>
</person-group><year iso-8601-date="1986">1986</year><article-title>Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes</article-title><source>The Journal of Experimental Medicine</source><volume>163</volume><fpage>1529</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1084/jem.163.6.1529</pub-id><pub-id pub-id-type="pmid">3011949</pub-id>
</element-citation></ref><ref id="ref-145"><label>Yewdell, Frank &#x00026; Gerhard (1981)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yewdell</surname><given-names>JW</given-names></name>
<name><surname>Frank</surname><given-names>E</given-names></name>
<name><surname>Gerhard</surname><given-names>W</given-names></name>
</person-group><year iso-8601-date="1981">1981</year><article-title>Expression of influenza A virus internal antigens on the surface of infected P815 cells</article-title><source>Journal of Immunology</source><volume>126</volume><fpage>1814</fpage><lpage>1819</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.126.5.1814</pub-id></element-citation></ref><ref id="ref-146"><label>Yount, Curtis &#x00026; Baric (2000)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yount</surname><given-names>B</given-names></name>
<name><surname>Curtis</surname><given-names>KM</given-names></name>
<name><surname>Baric</surname><given-names>RS</given-names></name>
</person-group><year iso-8601-date="2000">2000</year><article-title>Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model</article-title><source>Journal of Virology</source><volume>74</volume><fpage>10600</fpage><lpage>10611</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.22.10600-10611.2000</pub-id><pub-id pub-id-type="pmid">11044104</pub-id>
</element-citation></ref><ref id="ref-147"><label>Yount et al. (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yount</surname><given-names>B</given-names></name>
<name><surname>Curtis</surname><given-names>KM</given-names></name>
<name><surname>Fritz</surname><given-names>EA</given-names></name>
<name><surname>Hensley</surname><given-names>LE</given-names></name>
<name><surname>Jahrling</surname><given-names>PB</given-names></name>
<name><surname>Prentice</surname><given-names>E</given-names></name>
<name><surname>Denison</surname><given-names>MR</given-names></name>
<name><surname>Geisbert</surname><given-names>TW</given-names></name>
<name><surname>Baric</surname><given-names>RS</given-names></name>
</person-group><year iso-8601-date="2003">2003</year><article-title>Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>100</volume><fpage>12995</fpage><lpage>13000</lpage><pub-id pub-id-type="doi">10.1073/pnas.1735582100</pub-id><pub-id pub-id-type="pmid">14569023</pub-id>
</element-citation></ref><ref id="ref-148"><label>Yount et al. (2002)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yount</surname><given-names>B</given-names></name>
<name><surname>Denison</surname><given-names>MR</given-names></name>
<name><surname>Weiss</surname><given-names>SR</given-names></name>
<name><surname>Baric</surname><given-names>RS</given-names></name>
</person-group><year iso-8601-date="2002">2002</year><article-title>Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59</article-title><source>Journal of Virology</source><volume>76</volume><fpage>11065</fpage><lpage>11078</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.21.11065-11078.2002</pub-id><pub-id pub-id-type="pmid">12368349</pub-id>
</element-citation></ref><ref id="ref-149"><label>Yu et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>I-M</given-names></name>
<name><surname>Gustafson</surname><given-names>CLT</given-names></name>
<name><surname>Diao</surname><given-names>J</given-names></name>
<name><surname>Burgner</surname><given-names>JW</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="2005">2005</year><article-title>Recombinant Severe Acute Respiratory Syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>23280</fpage><lpage>23286</lpage><pub-id pub-id-type="doi">10.1074/jbc.M501015200</pub-id><pub-id pub-id-type="pmid">15849181</pub-id>
</element-citation></ref><ref id="ref-150"><label>Zhang et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>N</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
<name><surname>Zhu</surname><given-names>F</given-names></name>
<name><surname>Mao</surname><given-names>H</given-names></name>
<name><surname>Bai</surname><given-names>P</given-names></name>
<name><surname>Chen</surname><given-names>L-L</given-names></name>
<name><surname>Zeng</surname><given-names>T</given-names></name>
<name><surname>Peng</surname><given-names>M-M</given-names></name>
<name><surname>Qiu</surname><given-names>KL</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Yu</surname><given-names>M</given-names></name>
<name><surname>Xu</surname><given-names>S</given-names></name>
<name><surname>Zhao</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>N</given-names></name>
<name><surname>Zhou</surname><given-names>M</given-names></name>
</person-group><year iso-8601-date="2020">2020</year><article-title>Risk factors for poor outcomes of diabetes patients with COVID-19: a single-center, retrospective study in early outbreak in China</article-title><source>Frontiers in Endocrinology</source><volume>11</volume><elocation-id>571037</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2020.571037</pub-id><pub-id pub-id-type="pmid">33071977</pub-id>
</element-citation></ref><ref id="ref-151"><label>Zhao et al. (2021b)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>D</given-names></name>
<name><surname>Xu</surname><given-names>W</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Ge</surname><given-names>Y</given-names></name>
<name><surname>Yuan</surname><given-names>E</given-names></name>
<name><surname>Xiong</surname><given-names>Y</given-names></name>
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Li</surname><given-names>S</given-names></name>
<name><surname>Wu</surname><given-names>N</given-names></name>
<name><surname>Tian</surname><given-names>T</given-names></name>
<name><surname>Feng</surname><given-names>X</given-names></name>
<name><surname>Shu</surname><given-names>H</given-names></name>
<name><surname>Lang</surname><given-names>P</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Zhu</surname><given-names>F</given-names></name>
<name><surname>Shen</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Li</surname><given-names>P</given-names></name>
<name><surname>Zeng</surname><given-names>J</given-names></name>
</person-group><year iso-8601-date="2021">2021b</year><article-title>Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2</article-title><source>Protein &#x00026; Cell</source><volume>12</volume><fpage>734</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1007/s13238-021-00832-z</pub-id><pub-id pub-id-type="pmid">33770364</pub-id>
</element-citation></ref><ref id="ref-152"><label>Zhao et al. (2021a)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Sui</surname><given-names>L</given-names></name>
<name><surname>Wu</surname><given-names>P</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Wang</surname><given-names>Z</given-names></name>
<name><surname>Yu</surname><given-names>Y</given-names></name>
<name><surname>Hou</surname><given-names>Z</given-names></name>
<name><surname>Tan</surname><given-names>G</given-names></name>
<name><surname>Liu</surname><given-names>Q</given-names></name>
<name><surname>Wang</surname><given-names>G</given-names></name>
</person-group><year iso-8601-date="2021">2021a</year><article-title>A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response</article-title><source>Signal Transduction and Targeted Therapy</source><volume>6</volume><fpage>331</fpage><pub-id pub-id-type="doi">10.1038/s41392-021-00742-w</pub-id><pub-id pub-id-type="pmid">34471099</pub-id>
</element-citation></ref><ref id="ref-153"><label>Zinzula et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zinzula</surname><given-names>L</given-names></name>
<name><surname>Basquin</surname><given-names>J</given-names></name>
<name><surname>Bohn</surname><given-names>S</given-names></name>
<name><surname>Beck</surname><given-names>F</given-names></name>
<name><surname>Klumpe</surname><given-names>S</given-names></name>
<name><surname>Pfeifer</surname><given-names>G</given-names></name>
<name><surname>Nagy</surname><given-names>I</given-names></name>
<name><surname>Bracher</surname><given-names>A</given-names></name>
<name><surname>Hartl</surname><given-names>FU</given-names></name>
<name><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group><year iso-8601-date="2021">2021</year><article-title>High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the COVID-19 severe acute respiratory syndrome coronavirus 2</article-title><source>Biochemical and Biophysical Research Communications</source><volume>538</volume><fpage>54</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2020.09.131</pub-id><pub-id pub-id-type="pmid">33039147</pub-id>
</element-citation></ref><ref id="ref-154"><label>Z&#x000fa;&#x000f1;iga et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Z&#x000fa;&#x000f1;iga</surname><given-names>S</given-names></name>
<name><surname>Cruz</surname><given-names>JLG</given-names></name>
<name><surname>Sola</surname><given-names>I</given-names></name>
<name><surname>Mateos-G&#x000f3;mez</surname><given-names>PA</given-names></name>
<name><surname>Palacio</surname><given-names>L</given-names></name>
<name><surname>Enjuanes</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2010">2010</year><article-title>Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription</article-title><source>Journal of Virology</source><volume>84</volume><fpage>2169</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1128/JVI.02011-09</pub-id><pub-id pub-id-type="pmid">19955314</pub-id>
</element-citation></ref><ref id="ref-155"><label>Z&#x000fa;&#x000f1;iga et al. (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Z&#x000fa;&#x000f1;iga</surname><given-names>S</given-names></name>
<name><surname>Sola</surname><given-names>I</given-names></name>
<name><surname>Moreno</surname><given-names>JL</given-names></name>
<name><surname>Sabella</surname><given-names>P</given-names></name>
<name><surname>Plana-Dur&#x000e1;n</surname><given-names>J</given-names></name>
<name><surname>Enjuanes</surname><given-names>L</given-names></name>
</person-group><year iso-8601-date="2007">2007</year><article-title>Coronavirus nucleocapsid protein is an RNA chaperone</article-title><source>Virology</source><volume>357</volume><fpage>215</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.07.046</pub-id><pub-id pub-id-type="pmid">16979208</pub-id>
</element-citation></ref><ref id="ref-156"><label>Z&#x000fc;st et al. (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Z&#x000fc;st</surname><given-names>R</given-names></name>
<name><surname>Miller</surname><given-names>TB</given-names></name>
<name><surname>Goebel</surname><given-names>SJ</given-names></name>
<name><surname>Thiel</surname><given-names>V</given-names></name>
<name><surname>Masters</surname><given-names>PS</given-names></name>
</person-group><year iso-8601-date="2008">2008</year><article-title>Genetic interactions between an essential 3&#x02032;<italic toggle="yes">cis</italic> -acting RNA pseudoknot, replicase gene products, and the extreme 3&#x02032; end of the mouse coronavirus genome</article-title><source>Journal of Virology</source><volume>82</volume><fpage>1214</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1128/JVI.01690-07</pub-id><pub-id pub-id-type="pmid">18032506</pub-id>
</element-citation></ref></ref-list></back></article>